Ang Kaalaman/search/irr/doc-85374/
IRR of R.A. No. 9165 (August 30, 2002)
Implements
R.A. No. 9165
(NAR) VOL. 13 NOS. 1-4 / OCTOBER-DECEMBER 2002
[ DDB IMPLEMENTING RULES AND
REGULATIONS (IRR) OF REPUBLIC ACT NO.
9165, AUGUST 30, 2002, August 30, 2002 ]
IMPLEMENTING RULES AND REGULATIONS (IRR) OF
REPUBLIC ACT NO. 9165, OTHERWISE KNOWN AS THE
"COMPREHENSIVE DANGEROUS DRUGS ACT OF 2002"
THESE RULES AND REGULATIONS ARE HEREBY PROMULGATED TO
IMPLEMENT THE PROVISIONS OF REPUBLIC ACT NO. 9165, OTHERWISE
KNOWN AS THE "COMPREHENSIVE DANGEROUS DRUGS ACT OF 2002".
SECTION 1. This IRR, issued and promulgated pursuant to Section 94 of RA
9165, shall be referred to as the "COMPREHENSIVE DANGEROUS DRUGS
RULES OF 2002.”
SECTION 2. Declaration of Policy. — It is the policy of the State to safeguard
the integrity of its territory; and the well-being of its citizenry particularly the youth,
from the harmful effects of dangerous drugs on their physical and mental well-being,
and to defend the same against acts or omissions detrimental to their development
and preservation. In view of the foregoing, the State needs to enhance further the
efficacy of the law against dangerous drugs, it being one of today's more serious
social ills.
Toward this end, the government shall pursue an intensive and unrelenting campaign
against the trafficking and use of dangerous drugs and other similar substances
through an integrated system of planning, implementation and enforcement of anti-
drug abuse policies, programs and projects. The government shall, however, aim to
achieve a balance in the national drug control program so that people with legitimate
medical needs are not prevented from being treated with adequate amounts of
appropriate medications, which include the use of dangerous drugs.
It is further declared the policy of the State to provide effective mechanisms or
measures to re-integrate into society individuals who have fallen victims to drug
abuse or dangerous drug dependence through sustainable programs of treatment and
rehabilitation.
ARTICLE
Definition of Terms
SECTION 3. Definitions. — As used in this IRR, the following terms shall mean:
(a) Accreditation — the formal authorization issued by the
Department of Health (DOH) to an individual, partnership, corporationor association to operate a laboratory and rehabilitation facility after
compliance with the standards set at a maximum achievable level to
stimulate improvement over time;
(b) Act — refers to Republic Act No. 9165;
(c) Administer — any act of introducing any dangerous drug into the
body of any person, with or without his/her knowledge, by injection,
inhalation, ingestion or other means, or of committing any act of
indispensable assistance to person in administering a dangerous drug to
himself/herself unless administered by a duly licensed practitioner for
purposes of medication;
(d) Board or DDB — refers to the Dangerous Drugs Board under
Section 77, Article IX of the Act;
(e) Center — any of the treatment and rehabilitation centers which
undertake the treatment, after-care and follow-up treatment of drug
dependents as referred to in Section 75, Article VIII of the Act. It
includes institutions, agencies and the like whose purposes are: the
development of skills, arts, and technical know-how; counseling; and/or
inculcating civic, social, and moral values to drug patients, with the aim
of weaning them away from dangerous drugs and keeping them drug-
free, adapted to their families and peers, and readjusted into the
community as law abiding, useful and productive citizens;
(f) Chemical Diversion — the sale, distribution, supply or transport
of legitimately imported, in-transit; manufactured or procured controlled
precursors and essential chemicals, in diluted, mixtures or in
concentrated form, to any person or entity engaged in the manufacture of
any dangerous drug, and shall include packaging, repackaging, labeling
or concealment of such transaction through fraud, destruction of
documents, fraudulent use of permits, misdeclaration; use of front
companies or mail fraud;
(g) Clandestine Laboratory — any facility used for the illegal
manufacture of any dangerous drug and/or controlled precursor and
essential chemical;
(h) Confinement — refers to the residential treatment and rehabilitation of
trainees, clients and patients in a center;
(i) Confirmatory Test — an analytical test using a device, tool or equipment
with a different chemical or physical principle that is more specific which will
validate and confirm the result of the screening test. It refers to the second or further
analytical procedure to more accurately determine the presence of dangerous drugs
in a specimen;
(j) Controlled Delivery — the investigative technique of allowing an unlawful
or suspect consignment of any dangerous drug and/or controlled precursor and
essential chemical, equipment or paraphernalia or property believed to be derived
directly or indirectly from any offense, to pass into, through or out of the countryunder the supervision of an authorized officer, with a view to gathering evidence to
identify any person involved in any dangerous drug related offense, or to facilitate
prosecution of that offense;
(k) Controlled Precursors and Essential Chemicals — include those listed in
Tables I and II of the 1988 UN Convention Against Illicit Traffic in Narcotic Drugs
and Psychotropic Substances as enumerated in the attached annex, which is an
integral part of the Act;
(l) Cultivate or Culture — any act of knowingly planting, growing, raising, or
permitting the planting, growing or raising of any plant which is the source of a
dangerous drug;
(m) DOH-Accredited Physician — refers to a physician with background
experience on psychological/behavioral medicine whose application has been
approved and duly authorized by the DOH to conduct dependency examination on
persons believed to be using dangerous drugs;
(n) Dangerous Drugs — include those listed in the Schedules annexed to the
1961 Single Convention on Narcotic Drugs, as amended by the 1972 Protocol, and
in the Schedules annexed to the 1971 Single Convention on Psychotropic Substances
as enumerated in the attached annex which is an integral part of the Act;
(o) Deliver — any act of knowingly passing a dangerous drug to another,
personally or otherwise, and by any means, with or without consideration;
(p) Den, Dive or Resort — a place where any dangerous drug and/or controlled
precursor and essential chemical is administered, delivered, stored for illegal
purposes, distributed, sold or used in any form;
(q) Dispense — any act of giving away, selling or distributing medicine or any
dangerous drug with or without the use of prescription;
(r) Drug Dependence — as based on the World Health Organization definition,
it is a cluster of physiological, behavioral and cognitive phenomena of variable
intensity, in which the use of psychoactive drug takes on a high priority thereby
involving, among others, a strong desire or a sense of compulsion to take the
substance and the difficulties in controlling substance-taking behavior in terms of its
onset, termination, or levels of use;
(s) Drug Dependent — refers to a person suffering from drug dependence;
(t) Drug Syndicate — any organized group of two (2) or more persons forming
or joining together with the intention of committing any offense prescribed under the
Act;
(u) Employee of Den, Dive or Resort — the caretaker, helper, watchman,
lookout, and other persons working in the den, dive or resort, employed by the
maintainer, owner and/or operator where any dangerous drug and/or controlled
precursor and essential chemical is administered, delivered, distributed, sold or used,
with or without compensation, in connection with the operation thereof;(v) Financier — any person who pays for, raises or supplies money for, or
underwrites any of the illegal activities prescribed under the Act;
(w) Illegal Trafficking — the illegal cultivation, culture, delivery, administration,
dispensation, manufacture, sale, trading, transportation, distribution, importation,
exportation and possession of any dangerous drug and/or controlled precursor and
essential chemical;
(x) Income — revenues generated minus the expenses incurred by health
facilities in providing health services for the drug dependents;
(y) Instrument — any thing that is used or intended to be used, in any manner,
in the commission of illegal drug trafficking or related offenses;
(z) Laboratory — refers to the facility of a private or government agency that is
capable of testing a specimen to determine the presence of dangerous drugs therein;
(aa) Laboratory Equipment — the paraphernalia, apparatuses, materials or
appliances when used, intended for use or designed for use in the manufacture of
any dangerous drug and/or controlled precursor and essential chemical, such as
reaction vessel, preparative/purifying equipment, fermentors, separatory funnel,
flask, heating mantle, gas generator, or their substitute;
(bb) Manufacture — the production, preparation, compounding or processing of
any dangerous drug and/or controlled precursor and essential chemical, either
directly or indirectly or by extraction from substances of natural origin, or
independently by means of chemical synthesis or by a combination of extraction and
chemical synthesis, and shall include any packaging or repackaging of such
substances, design or configuration of its form, or labeling or relabeling of its
container; except that such terms do not include the preparation, compounding,
packaging or labeling of a drug or other substances by a duly authorized practitioner
as an incident to his/her administration or dispensation of such drug or substance in
the course of his/her professional practice including research, teaching and chemical
analysis of dangerous drug or such substances that are not intended for sale or for
any other purpose;
(cc) Cannabis or commonly known as "Marijuana" or "Indian Hemp' or by its any
other name — embraces every kind, class, genus, or specie of the plant Cannabis
sativa L, including, but not limited to, Cannabis americana, hashish, bhang, guaza,
churrus and ganjab, and embraces every kind, class and character of marijuana,
whether dried or fresh and flowering, flowering or fruiting tops; or any part or
portion of the plant and seeds thereof, and all its geographic varieties, whether as a
reefer, resin, extract, tincture or in any form whatsoever;
(dd) Methylenedioxymethamphetamine (MDMA) or commonly known as
"Ecstasy," or by its any other name — refers to the drug having such chemical
composition, including any of its isomers or derivatives in any form;
(ee) Methamphetamine Hydrochloride or commonly known as "Shabu", "Ice",
"Meth", or by its any other name — refers to the drug having such chemical
composition, including any of its isomers or derivatives in any form;(ff) Opium — refers to the coagulated juice of the opium poppy (Papaver
somniferum L.) and embraces every kind, class and character of opium, whether
crude or prepared; the ashes or refuse of the same, narcotic preparations thereof or
therefrom; morphine or any alkaloid of opium; preparations in which opium,
morphine or any alkaloid of opium enters as an ingredient; opium poppy; opium
poppy straw; and leaves or wrappings of opium leaves, whether prepared for use or
not;
(gg) Opium Poppy — refers to any part of the plant of the species Papaver
somniferum L., Papaver setigerum DC, Papaver orientale, Papaver bracteatum and
Papaver rhoeas, which includes the seeds, straws, branches, leaves or any part
thereof, or substances derived therefrom, even for floral, decorative and culinary
purposes;
(hh) PDEA — refers to the Philippine Drug Enforcement Agency under Section
82 Article IX of the Act;
(ii) Person — any entity, natural or juridical, including among others, a
corporation, partnership, trust or estate, joint stock company, association, syndicate;
joint venture or other unincorporated organization or group capable of acquiring
rights or entering into obligations;
(jj) Planting of Evidence — the willful act of any person of maliciously and
surreptitiously inserting, placing, adding or attaching directly or indirectly, through
any overt or covert act, whatever quantity of any dangerous drug and/or controlled
precursor and essential chemical in the person, house, effects or in the immediate
vicinity of an innocent individual for the purpose of implicating, incriminating or
imputing the commission of any violation of the Act;
(kk) Practitioner — any person who is a licensed physician, dentist, chemist,
medical technologist, nurse, midwife, veterinarian or pharmacist in the Philippines;
(ll) Protector/Coddler — any person who knowingly and willfully consents to
the unlawful acts provided for in the Act and uses his/her influence, power or
position in shielding, harboring, screening or facilitating the escape of any person
he/she knows, or has reasonable grounds to believe on or suspects, has violated the
provisions of the Act in order to prevent the arrest, prosecution and conviction of the
violator;
(mm) Pusher — any person who sells, trades, administers, dispenses, delivers or
gives away to another, on any term whatsoever, or distributes, dispatches in transit or
transports dangerous drugs or who acts as a broker in any of such transactions, in
violation a the Act;
(nn) Rehabilitation — the dynamic process, including after-care and follow-up
treatment, directed towards the physical, emotional/psychological, vocational, social
and spiritual change/enhancement of a drug dependent to enable him/her to live
without dangerous drugs, enjoy the fullest life compatible with his/her capabilities
and potentials and render him/her able to become a law-abiding and productive
member of the community;(oo) School — any educational institution, private or public, undertaking
educational operation for pupils/students pursuing certain studies at defined levels,
receiving instructions from teachers, usually located in a building or a group of
buildings in a particular physical or cyber site;
(pp) Screening Test — a rapid test performed to establish potential/presumptive
positive result. It refers to the immunoassay test to eliminate a "negative" specimen,
i.e. one without the presence of dangerous drugs, from further consideration and to
identify the presumptively positive specimen that requires confirmatory test;
(qq) Trading — transactions involving the illegal trafficking of dangerous drugs
and/or controlled precursors and essential chemicals using electronic devices such
as, but not limited to, text messages, e-mail, mobile or landlines, two-way radios,
internet, instant messengers and chat rooms or acting as a broker in any of such
transactions whether for money or any other consideration in violation of the Act;
(rr) Use — any act of injecting, intravenously or intramuscularly, of consuming,
either by chewing, smoking, sniffing, eating, swallowing, drinking or otherwise
introducing into the physiological system of the body, any of the dangerous drugs.
ARTICLE II
Unlawful Acts and Penalties
SECTION 4. Importation of Dangerous Drugs and/or Controlled Precursors and
Essential Chemicals. — The penalty of life imprisonment to death and a fine ranging
from Five hundred thousand pesos (P500,000.00) to Ten million pesos
(P10,000,000.00) shall be imposed upon any person, who, unless authorized by law,
shall import or bring into the Philippines any dangerous drug, regardless of the
quantity and purity involved, including any and all species of opium poppy or any
part thereof or substances derived therefrom even for floral, decorative and culinary
purposes.
The penalty of imprisonment ranging from twelve (12) years and one (1) day to
twenty (20) years and a fine ranging from One hundred thousand pesos
(P100,000.00) to Five hundred thousand pesos (P500,000.00) shall be imposed upon
any person, who, unless authorized by law, shall import any controlled precursor and
essential chemical.
The maximum penalty provided for under this Section shall be imposed upon any
person, who, unless authorized under the Act, shall import or bring into the
Philippines any dangerous drug and/or controlled precursor and essential chemical
through the use of a diplomatic passport, diplomatic facilities or any other means
involving his/her official status intended to facilitate the unlawful entry of the same.
In addition, the diplomatic passport shall be confiscated and canceled.
The maximum penalty provided for under this Section shall be imposed upon any
person, who organizes, manages, or acts as a "financier" of any of the illegal
activities prescribed in this Section.
The penalty of twelve (12) years and one (1) day to twenty (20) years of
imprisonment and a fine ranging from One hundred thousand pesos (P100,000.00) toFive hundred thousand pesos (P500,000.00) shall be imposed upon any person, who
acts as a "protector/coddler" of any violator of the provisions under this Section.
SECTION 5. Sale, Trading, Administration, Dispensation, Delivery, Distribution
and Transportation of Dangerous Drugs and/or Controlled Precursors and Essential
Chemicals. — The penalty of life imprisonment to death and a fine ranging from
Five hundred thousand pesos (P500,000.00) to Ten million pesos (P10,000,000.00)
shall be imposed upon any person, who, unless authorized by law, shall sell, trade,
administer, dispense, deliver, give away to another, distribute, dispatch in transit or
transport any dangerous drug, including any and all species of opium poppy
regardless of the quantity and purity involved, or shall act as a broker in any of such
transactions.
The penalty of imprisonment ranging from twelve (12) years and one (1) day to
twenty (20) years and a fine ranging from One hundred thousand pesos
(P100,000.00) to Five hundred thousand pesos (P500,000.00) shall be imposed upon
any person, who, unless authorized by law, shall sell, trade, administer, dispense,
deliver, give away to another, distribute, dispatch in transit or transport any
controlled precursor and essential chemical, or shall act as a broker in such
transactions.
If the sale, trading, administration, dispensation, delivery, distribution or
transportation of any dangerous drug and/or controlled precursor and essential
chemical transpires within one hundred (100) meters from the school, the maximum
penalty shall be imposed in every case.
For drug pushers who use minors or mentally incapacitated individuals as runners,
couriers and messengers, or in any other capacity directly connected to the
dangerous drugs and/or controlled precursors and essential chemicals trade, the
maximum penalty shall be imposed in every case.
If the victim of the offense is a minor or a mentally incapacitated individual, or
should a dangerous drug and/or a controlled precursor and essential chemical
involved in any offense herein provided be the proximate cause of death of a victim
thereof, the maximum penalty provided for under this Section shall be imposed.
The maximum penalty provided for under this Section, shall be imposed upon any
person who organizes, manages or acts as a "financier" of any of the illegal activities
prescribed in this Section.
The penalty of twelve (12) years and one (1) day to twenty (20) years of
imprisonment and a fine ranging from One hundred thousand pesos (P100,000.00) to
Five hundred thousand pesos (P500,000.00) shall be imposed upon any person, who
acts as a "protector/coddler" of any violator of the provisions under this Section.
SECTION 6. Maintenance of a Den, Dive or Resort. — The penalty of life
imprisonment to death and a fine ranging from Five hundred thousand pesos
(P500,000.00) to Ten million pesos (P10,000,000.00) shall be imposed upon any
person or group of persons who shall maintain a den, dive or resort where any
dangerous drug is used or sold in any form.The penalty of imprisonment ranging from twelve (12) years and one (1) day to
twenty (20) years and a fine ranging from One hundred thousand pesos
(P100,000.00) to Five hundred thousand pesos (P500,000.00) shall be imposed upon
any person or group of persons who shall maintain a den, dive, or resort where any
controlled precursor and essential chemical is used or sold in any form.
The maximum penalty provided for under this Section shall be imposed in every
case where any dangerous drug is administered, delivered or sold to a minor who is
allowed to use the same in such a place.
Should any dangerous drug be the proximate cause of the death of a person using the
same in such den, dive or resort, the penalty of death and a fine ranging from One
million (P1,000,000.00) to Fifteen million pesos (P15,000,000.00) shall be imposed
on the maintainer, owner and/or operator.
If such den, dive or resort is owned by a third person, the same shall be confiscated
and escheated in favor of the government: Provided, that the criminal complaint
shall specifically allege that such place is intentionally used in the furtherance of the
crime; Provided, further, that the prosecution shall prove such intent on the part of
the owner to use the property for such purpose, Provided, finally, that the owner
shall be included as an accused in the criminal complaint.
The maximum penalty provided for under this Section shall be imposed upon any
person who organizes, manages or acts as a "financier' of any of the illegal activities
prescribed in this Section.
The penalty of twelve (12) years and one (1) day to twenty (20) years of
imprisonment and a fine ranging from One hundred thousand pesos (P100,000.00) to
Five hundred thousand pesos (P500,000.00) shall be imposed upon any person, who
acts as a "protector/coddler" of any violator of the provisions under this Section.
SECTION 7. Employees and Visitors of a Den, Dive or Resort. — The penalty of
imprisonment ranging from twelve (12) years and one (1) day to twenty (20) years
and a fine ranging from One hundred thousand pesos (P100,000.00) to Five hundred
thousand pesos (P500,000.00) shall be imposed upon:
(a) Any employee of den, dive or resort, who is aware of the nature of the place as
such; And
(b) Any person who, not being included in the provisions of the next preceding
paragraph, is aware of the nature of the place as such and shall knowingly visit the
same.
SECTION 8. Manufacture of Dangerous Drugs and/or Controlled Precursors
and Essential Chemicals. — The penalty of life imprisonment to death and a fine
ranging from Five hundred thousand pesos (P500,000.00) to Ten million pesos
(P10,000,000.00) shall be imposed upon any person, who unless authorized by law,
shall engage in the manufacture of any dangerous drug.
The penalty of imprisonment ranging from twelve (12) years and one (1) day to
twenty (20) years and a fine ranging from One hundred thousand pesos
(P100,000.00) to Five hundred thousand pesos (P500,000.00) shall be imposed uponany person, who unless authorized by law, shall manufacture any controlled
precursor and essential chemical.
The presence of any controlled precursor and essential chemical or laboratory
equipment in the clandestine laboratory is a prima facie proof of manufacture of any
dangerous drug. It shall be considered an aggravating circumstance if the clandestine
laboratory is undertaken or established under the following circumstances:
a) Any phase of the manufacturing process was conducted in the
presence or with the help of minor/s;
b) Any phase or manufacturing process was established or undertaken
within one hundred (100) meters of a residential, business, church or
school premises;
c) Any clandestine laboratory was secured or protected with booby
traps;
d) Any clandestine laboratory was concealed with legitimate business
operations; or
e) Any employment of a practitioner, chemical engineer, public
official or foreigner.
The maximum penalty provided for under this Section shall be imposed upon any
person, who organizes, manages or acts as a "financier" of any of the illegal
activities prescribed in this Section.
The penalty of twelve (12) years and one (1) day to twenty (20) years of
imprisonment and a fine ranging from One hundred thousand pesos (P100,000.00) to
Five hundred thousand pesos (P500,000.00) shall be imposed upon any person, who
acts as a "protector/coddler" of any violator of the provisions under this Section.
SECTION 9. Illegal Chemical Diversion of Controlled Precursors and Essential
Chemicals. — The penalty of imprisonment ranging from twelve (12) years and one
(1) day to twenty (20) years and a fine ranging from One hundred thousand pesos
(P100,000.00) to Five hundred thousand pesos (P500,000.00) shall be imposed upon
any person, who unless authorized by law, shall illegally divert any controlled
precursor and essential chemical.
SECTION 10. Manufacture or Delivery of Equipment, Instrument, Apparatus and
Other Paraphernalia for Dangerous Drugs and/or Controlled Precursors and
Essential Chemicals. — The penalty of imprisonment ranging from twelve (12)
years and one (1) day to twenty (20) years and a fine ranging from One hundred
thousand pesos (P100,000.00) to Five hundred thousand pesos (P500,000.00) shall
be imposed upon any person who shall deliver, possess with intent to deliver, or
manufacture with intent to deliver equipment, instrument, apparatus and other
paraphernalia for dangerous drugs, knowing, or under circumstances where one
reasonably should know, that it will be used to plant, propagate, cultivate, grow,
harvest manufacture, compound, convert, produce, process, prepare, test, analyze,
pack, repack, store, contain or conceal any dangerous drug and/or controlled
precursor and essential chemical in violation of the Act.The penalty of imprisonment ranging from six (6) months and one (1) day to four (4)
years and a fine ranging from Ten thousand pesos (P10,000.00) to Fifty thousand
pesos (P50,000.00) shall be imposed if it will be used to inject, ingest, inhale or
otherwise introduce into the human body a dangerous drug in violation of the Act.
The maximum penalty provided for under this Section shall be imposed upon any
person, who uses a minor or a mentally incapacitated individual to deliver such
equipment, instrument, apparatus and other paraphernalia for dangerous drugs.
SECTION 11. Possession of Dangerous Drugs. — The penalty of life
imprisonment to death and a fine ranging from Five hundred thousand pesos
(P500,000.00) to Ten million pesos (P10,000,000.00) shall be imposed upon any
person, who, unless authorized by law, shall possess any dangerous drug in the
following quantities, regardless of the degree of purity thereof:
a) 10 grams or more of opium;
b) 10 grams or more of morphine;
c) 10 grams or more of heroin;
d) 10 grams or more of cocaine or cocaine hydrochloride;
e) 50 grams or more of methamphetamine hydrochloride or "shabu";
f) 10 grams or more of marijuana resin or marijuana resin oil;
g) 500 grams or more of marijuana; and
h) 10 grams or more of other dangerous drugs such as, but not limited
to, methylenedioxymethamphetamine (MDMA) or "ecstasy",
paramethoxyamphetamine (PMA), trimethoxyamphetamine (TMA),
lysergic acid diethylamine (LSD), gamma hydroxybutyrate (GHB), and
those similarly designed or newly introduced drugs and their derivatives
without having any therapeutic value or if the quantity possessed is far
beyond therapeutic requirements, as determined and promulgated by the
Board in accordance with Section 93, Article XI of the Act.
Otherwise, if the quantity involved is less than the foregoing quantities, the penalties
shall be graduated as follows:
1. Life imprisonment and a fine ranging from Four hundred thousand
pesos (P400,000.00) to Five hundred thousand pesos (P500,000.00), if
the quantity of methamphetamine hydrochloride or "shabu" is ten (10)
grams or more but less than fifty (50) grams;
2. Imprisonment of twenty (20) years and one (1) day to life
imprisonment and a fine ranging from Four hundred thousand pesos
(P400,000.00) to Five hundred thousand pesos (P500,000.00), if the
quantities of dangerous drugs are five (5) grams or more but less than ten
(10) grams of opium, morphine, heroin, cocaine or cocaine
hydrochloride, marijuana resin or marijuana resin oil, methamphetaminehydrochloride or "shabu", or other dangerous drugs such as, but not
limited to, MDMA or "ecstasy", PMA, TMA, LSD, GHBs and those
similarly designed or newly introduced drugs and their derivatives,
without having any therapeutic value or if the quantity possessed is far
beyond therapeutic requirements; or three hundred (300) grams or more
but less than five hundred (500) grams of marijuana; and
3. Imprisonment of twelve (12) years and one (1) day to twenty (20)
years and a fine ranging from Three hundred thousand pesos
(P300,000.00) to Four hundred thousand pesos (P400,000.00), if the
quantities of dangerous drugs are less than five (5) grams of opium,
morphine, heroin, cocaine or cocaine hydrochloride, marijuana resin or
marijuana resin oil, methamphetamine hydrochloride or "shabu", or other
dangerous drugs such as, but not limited to, MDMA or "ecstasy", PMA,
TMA, LSD, GHB, and those similarly designed or newly introduced
drugs and their derivatives, without having any therapeutic value or if the
quantity possessed is far beyond therapeutic requirements; or less than
three hundred (300) grams of marijuana.
SECTION 12. Possession of Equipment, Instrument, Apparatus and Other
Paraphernalia for Dangerous Drugs. — The penalty of imprisonment ranging from
six (6) months and one (1) day to four (4) years and a fine ranging from Ten
thousand pesos (P10,000.00) to Fifty thousand pesos (P50,000.00) shall be imposed
upon any person, who, unless authorized by law, shall possess or have under his/her
control any equipment, instrument, apparatus and other paraphernalia fit or intended
for smoking, consuming, administering, injecting, ingesting, or introducing any
dangerous drug into the body: Provided, that in the case of medical practitioners and
various professionals who are required to carry such equipment, instrument,
apparatus and other paraphernalia in the practice of their profession, the Board shall
prescribe the necessary implementing guidelines thereof.
The possession of such equipment, instrument, apparatus and other paraphernalia fit
or intended for any of the purposes enumerated in the preceding paragraph shall be
prima facie evidence that the possessor has smoked, consumed, administered to
himself/herself, injected, ingested or used a dangerous drug and shall be presumed to
have violated Section 15 of the Act.
SECTION 13. Possession of Dangerous Drugs During Parties, Social Gatherings
or Meetings. — Any person found possessing any dangerous drug during a party, or
at a social gathering or meeting, or in the proximate company of at least two (2)
persons, shall suffer the maximum penalties provided for in Section 11 of the Act,
regardless of the quantity and purity of such dangerous drugs.
The phrase "company of at least two (2) persons" shall mean the accused or suspect
plus at least two (2) others, who may or may not be in possession of any dangerous
drug.
SECTION 14. Possession of Equipment, Instrument, Apparatus and Other
Paraphernalia for Dangerous Drugs During Parties, Social Gatherings or
Meetings. — The maximum penalty provided for in Section 12 of the Act shall be
imposed upon any person, who shall possess or have under his/her control any
equipment, instrument, apparatus and other paraphernalia fit or intended forsmoking, consuming, administering, injecting, ingesting, or introducing any
dangerous drug into the body, during parties, social gatherings or meetings, or in the
proximate company of at least two (2) persons.
The phrase "company of at least two (2) persons" shall mean the accused or suspect
plus at least two (2) others, who may or may not be in possession of any equipment,
instrument, apparatus and other paraphernalia for dangerous drugs.
SECTION 15. Use of Dangerous Drugs. — A person apprehended or arrested, who
is found to be positive for use of any dangerous drug, after a confirmatory test, shall
be imposed a penalty of a minimum of six (6) months rehabilitation in a government
center for the first offense, subject to the provision of Article VIII of the Act. If
apprehended using any dangerous drug for the second time, he/she shall suffer the
penalty of imprisonment ranging from six (6) years and one (1) day to twelve (12)
years and a fine ranging from Fifty thousand pesos (P50,000.00) to Two hundred
thousand pesos (P200,000.00): Provided, that this Section shall not be applicable
where the person tested is also found to have in his/her possession such quantity of
any dangerous drug provided for under Section 11 of the Act, in which case the
provisions stated therein shall apply.
SECTION 16. Cultivation or Culture of Plants Classified as Dangerous Drugs or
are Sources Thereof. — The penalty of life imprisonment to death and a fine ranging
from Five hundred thousand pesos (P500,000.00) to Ten million peso
(P10,000,000.00) shall be imposed upon any person, who shall plant, cultivate or
culture marijuana, opium poppy or any other plant regardless of quantity, which is or
may hereafter be classified as a dangerous drug or as a source from which any
dangerous drug may be manufactured or derived: Provided, that in the case of
medical laboratories and medical research centers which cultivate or culture
marijuana, opium poppy and other plants, or materials of such dangerous drugs for
medical experiments and research purposes, or for the creation of new types of
medicine, the Board shall prescribe the necessary implementing guidelines for the
proper cultivation, culture, handling, experimentation and disposal of such plants
and materials.
The land or portions thereof and/or greenhouses on which any of said plant is
cultivated or cultured shall be confiscated and escheated in favor of the State, unless
the owner thereof can prove lack of knowledge of such cultivation or culture despite
the exercise of due diligence on his/her part. If the land involved is part of the
public domain, the maximum penalty provided for under this Section shall be
imposed upon, the offender.
The maximum penalty provided for under this Section shall be imposed upon any
person, who organizes, manages or acts as a "financier" of any of the illegal
activities prescribed in this Section.
The penalty of twelve (12) years and one (1) day to twenty (20) years of
imprisonment and a fine ranging from One hundred thousand pesos (P100,000.00) to
Five hundred thousand pesos (P500,000.00) shall be imposed upon any person, who
acts as a "protector/coddler" of any violator of the provisions under this Section.
SECTION 17. Maintenance and Keeping of Original Records of Transactions on
Dangerous Drugs and/or Controlled Precursors and Essential Chemicals. — Thepenalty of imprisonment ranging from one (1) year and one (1) day to six (6) years
and a fine ranging from Ten thousand pesos (P10,000.00) to Fifty thousand pesos
(P50,000.00) shall be imposed upon any practitioner, manufacturer, wholesaler,
importer, distributor, dealer or retailer who violates or fails to comply with the
maintenance and keeping of the original records of transactions on any dangerous
drug and/or controlled precursor and essential chemical in accordance with Section
40 of the Act.
An additional penalty shall be imposed through the revocation of the license to
practice his/her profession, in case of a practitioner, or of the business, in case of a
manufacturer, seller, importer, distributor, dealer or retailer.
SECTION 18. Unnecessary Prescription of Dangerous Drugs. — The penalty of
imprisonment ranging from twelve (12) years and one (1) day to twenty (20) years
and a fine ranging from One hundred thousand pesos (P100,000.00) to Five hundred
thousand pesos (P500,000.00) and the additional penalty of the revocation of his/her
license to practice shall be imposed upon the practitioner, who shall prescribe any
dangerous drug to any person whose physical or physiological condition does not
require its use or in the dosage prescribed therein, as determined by the Board in
consultation with recognized competent experts who are authorized representatives
of professional organizations of practitioners, particularly those who are involved in
the care of persons with severe pain.
SECTION 19. Unlawful Prescription of Dangerous Drugs. — The penalty of life
imprisonment to death and a fine ranging from Five hundred thousand pesos
(P500,000.00) to Ten million pesos (P10,000,000.00) shall be imposed upon any
person, who, unless authorized by law, shall make or issue a prescription or any
other writing purporting to be a prescription for any dangerous drug.
SECTION 20. Confiscation and Forfeiture of the Proceeds or Instruments of the
Unlawful Act, Including the Properties or Proceeds Derived from the Illegal
Trafficking of Dangerous Drugs and/or Precursors and Essential Chemicals. —
Every penalty imposed for the unlawful importation, sale, trading, administration,
dispensation, delivery, distribution, transportation or manufacture of any dangerous
drug and/or controlled precursor and essential chemical, the cultivation or culture of
plants which are sources of dangerous drugs, and the possession of any equipment,
instrument, apparatus and other paraphernalia for dangerous drugs including other
laboratory equipment, shall carry with it the confiscation and forfeiture, in favor of
the government, of all the proceeds and properties derived from the unlawful act,
including, but not limited to, money and other assets obtained thereby, and the
instruments or tools with which the particular unlawful act was committed, unless
they are the property of a third person not liable for the unlawful act, but those
which are not of lawful commerce shall be ordered destroyed without delay pursuant
to the provisions of Section 21 of the Act.
After conviction in the Regional Trial Court in the appropriate criminal case filed,
the court shall immediately schedule a hearing for the confiscation and forfeiture of
all the proceeds of the offense and all the assets and properties of the accused either
owned or held by him or in the name of some other persons if the same shall be
found to be manifestly out of proportion to his/her lawful income: Provided,
however, that if the forfeited property is a vehicle, the same shall be auctioned off
not later than five (5) days upon order of confiscation or forfeiting.During the pendency of the case in the Regional Trial Court, no property, or income
derived therefrom, which may be confiscated and forfeited, shall be disposed,
alienated or transferred and the same shall be in custodia legis and no bond shall be
admitted for the release of the same.
The proceeds of any sale or disposition of any property confiscated or forfeited
under this Section shall be used to pay all proper expenses incurred in the
proceedings for the confiscation, forfeiture, custody and maintenance of the property
pending disposition, as well as expenses for publication and court costs. The
proceeds in excess of the above expenses shall accrue to the Board to be used in its
campaign against illegal drugs.
SECTION 21. Custody and Disposition of Confiscated, Seized and/or Surrendered
Dangerous Drugs, Plant Sources of Dangerous Drugs, Controlled Precursors and
Essential Chemicals, Instruments/Paraphernalia and/or Laboratory Equipment. —
The PDEA shall take charge and have custody of all dangerous drugs, controlled
precusors and essential chemicals, as well as instruments/paraphernalia and/or
laboratory equipment so confiscated, seized and/or surrendered, for proper
disposition in the following manner:
a. The apprehending officer/team having initial custody and control
of the drugs shall, immediately after seizure and confiscation, physically
inventory and photograph the same in the presence of the accused or the
person/s from whom such items were confiscated and/or seized, or
his/her representative or counsel, a representative from the media and the
Department of Justice (DOJ), and any elected public official who shall be
required to sign the copies of the inventory and be given a copy thereof:
Provided, that the physical inventory and photograph shall be conducted
at the place where the search warrant is served; or at the nearest police
station or at the nearest office of the apprehending officer/team,
whichever is practicable, in case of warrantless seizures; Provided,
further, that non-compliance with these requirements under justifiable
grounds, as long as the integrity and the evidentiary value of the seized
items are properly preserved by the apprehending officer/team, shall not
render void and invalid such seizures of and custody over said items;
b. Within twenty-four (24) hours upon confiscation/seizure of
dangerous drugs, plant sources of dangerous drugs, controlled precursors
and essential chemicals, as well as instruments/paraphernalia and/or
laboratory equipment, the same shall be submitted to the PDEA Forensic
Laboratory for a qualitative and quantitative examination;
c) A certification of the forensic laboratory examination results,
which shall be done under oath by the forensic laboratory examiner, shall
be issued within twenty-four (24) hours after the receipt of the subject
item/s: Provided, that when the volume of the dangerous drugs, plant
sources of dangerous drugs, and controlled precursors and essential
chemicals does not allow the completion of testing within the time frame,
a partial laboratory examination report shall be provisionally issued
stating therein the quantities of dangerous drugs still to be examined by
the forensic laboratory: Provided, however, that a final certification shallbe issued on the completed forensic laboratory examination on the same
within the next twenty-four (24) hours;
d) After the filing of the criminal case, the court shall, within
seventy-two (72) hours, conduct an ocular inspection of the confiscated,
seized and/or surrendered dangerous drugs, plant sources of dangerous
drugs, and controlled precursors and essential chemicals, including the
instruments/paraphernalia and/or laboratory equipment, and through the
PDEA shall, within twenty-four (24) hours thereafter, proceed with the
destruction or burning of the same, in the presence of the accused or the
person/s from whom such items were confiscated and/or seized, or
his/her representative or counsel, a representative from the media and the
DOJ, civil society groups and any elected public official. The Board
shall draw up the guidelines on the manner of proper disposition and
destruction of such item/s which shall be borne by the offender:
Provided, that those item/s of lawful commerce, as determined by the
Board, shall be donated, used or recycled for legitimate purposes;
Provided, further, that a representative sample, duly weighed and
recorded is retained;
e. The Board shall then issue a sworn certification as to the fact of
destruction or burning of the subject item/s which, together with the
representative sample/s in the custody of the PDEA, shall be submitted to
the court having jurisdiction over the case. In cases of seizures where no
person is apprehended and no criminal case is filed, the PDEA may order
the immediate destruction or burning of seized dangerous drugs and
controlled precursors and essential chemicals under guidelines set by the
Board. In all instances, the representative sample/s shall be kept to a
minimum quantity as determined by the Board;
f. The alleged offender or his/her representative or counsel shall be
allowed to personally observe all of the above proceedings and his/her
presence shall not constitute an admission of guilt. In case the said
offender or accused refuses or fails to appoint a representative after due
notice in writing to the accused or his/her counsel within seventy-two
(72) hours before the actual burning or destruction of the evidence in
question, the Secretary of Justice shall appoint a member of the public
attorney's office to represent the former;
(g) After the promulgation and judgment in the criminal case wherein
the representative sample/s was presented as evidence in court, the trial
prosecutor shall inform the Board of the final termination of the case and,
in turn, shall request the court for leave to turn over the said
representative sample/s to the PDEA for proper disposition and
destruction within twenty-four (24) hours from receipt of the same; and
(h) Transitory Provision:
h.1) Within twenty-four (24) hours from the effectivity of
the Act, dangerous drugs defined herein which are presently
in possession of law enforcement agencies shall, with leave of
court, be burned or destroyed, in the presence ofrepresentatives of the court, DOJ, Department of Health
(DOH) and the accused and/or his/her counsel; and
h.2) Pending the organization of the PDEA, the custody,
disposition, and burning or destruction of seized/surrendered
dangerous drugs provided under this Section shall be
implemented by the DOH.
In the meantime that the PDEA has no forensic laboratories and/or evidence rooms,
as well as the necessary personnel of its own in any area of its jurisdiction, the
existing National Bureau of Investigation (NBI) and Philippine National Police
(PNP) forensic laboratories shall continue to examine or conduct screening and
confirmatory test on the seized/surrendered evidence whether these be dangerous
drugs, plant sources of dangerous drugs, controlled precursors and essential
chemicals, instruments paraphernalia and/or laboratory equipment; and the NBI and
the PNP shall continue to have custody of such evidence for use in court and until
disposed of, burned or destroyed in accordance with the foregoing rules: Provided,
that pending appointment/designation of the full complement of the representatives
from the media, DOJ, or elected public official, the inventory of the said evidence
shall continue to be conducted by the arresting NBI and PNP operatives under their
existing procedures unless otherwise directed in writing by the DOH or PDEA, as
the case may be.
SECTION 22. Grant of Compensation, Reward and Award. — Compensation,
reward and award shall, upon the recommendation of the Board, be granted to any
person providing information and to law enforcers participating in the operation,
which results in the successful confiscation, seizure or surrender of dangerous drugs,
plant sources of dangerous drugs, and controlled precursors and essential chemicals,
subject to the compensation, reward and award system promulgated by the Board.
SECTION 23. Plea-Bargaining Provision. — Any person charged under any
provision of the Act regardless of the imposable penalty shall not be allowed to avail
of the provision on plea-bargaining.
SECTION 24. Non-Applicability of the Probation Law for Drug Traffickers and
Pushers. — Any person convicted of drug trafficking or pushing under the Act,
regardless of the penalty imposed by the court, cannot avail of the privilege granted
by the Probation Law or Presidential Decree No. 968, as amended.
SECTION 25. Qualifying Aggravating Circumstances In the Commission of a
Crime by an Offender Under the Influence of Dangerous Drugs. — Notwithstanding
the provisions of any law to the contrary, a positive finding for the use of dangerous
drugs shall be a qualifying aggravating circumstance in the commission of a crime
by an offender, and the application of the penalty provided for in the Revised Penal
Code shall be applicable.
Positive finding refers to the result of confirmatory test.
SECTION 26. Attempt or Conspiracy. — Any attempt or conspiracy to commit the
following unlawful acts shall be penalized by the same penalty prescribed for the
commission of the same provided under the Act:a. Importation of any dangerous drug and/or controlled precursor
and essential chemical;
b. Sale, trading, administration, dispensation, delivery, distribution
and transportation of any dangerous drug and/or controlled precursor and
essential chemical;
c. Maintenance of a den, dive or resort where any dangerous drug is
used in any form;
d. Manufacture of any dangerous drug and/or controlled precursor
and essential chemical; and
e. Cultivation or culture of plants which are sources of dangerous
drugs.
SECTION 27. Criminal Liability of a Public Officer or Employee for
Misappropriation; Misapplication or Failure to Account for the Confiscated, Seized
and/or Surrendered Dangerous Drugs, Plant Sources of Dangerous Drugs,
Controlled Precursors and Essential Chemicals, Instruments/Paraphernalia and/or
Laboratory Equipment Including the Proceeds or Properties Obtained from the
Unlawful Act Committed. — The penalty of life imprisonment to death and a fine
ranging from Five hundred thousand pesos (P500,000.00) to Ten million pesos
(P10,000,000.00), in addition to absolute perpetual disqualification from any public
office, shall be imposed upon any public officer or employee who misappropriates,
misapplies or fails to account for confiscated, seized or surrendered dangerous
drugs, plant sources of dangerous drugs, controlled precursors and essential
chemicals, instruments/paraphernalia and/or laboratory equipment including the
proceeds or properties obtained from the unlawful acts as provided for in the Act.
Any elective local or national official found to have benefited from the proceeds of
the trafficking of dangerous drugs as prescribed in the Act, or have received any
financial or material contributions or donations from natural or juridical persons
found guilty of trafficking dangerous drugs as prescribed in the Act, shall be
removed from office and perpetually disqualified from holding any elective or
appointive positions in the government, its divisions, subdivisions, and
intermediaries, including government-owned or -controlled corporations.
SECTION 28. Criminal Liability of Government Officials and Employees. — The
maximum penalties of the unlawful acts provided for in the Act shall be imposed, in
addition to absolute perpetual disqualification from any public office, if those found
guilty of such unlawful acts are government officials and employees.
SECTION 29. Criminal Liability for Planting of Evidence. — Any person who is
found guilty of "planting" any dangerous drug and/or controlled precursor and
essential chemical, regardless of quantity and purity, shall suffer the penalty of
death.
SECTION 30. Criminal Liability of Officers of Partnerships, Corporations,
Associations or Other Juridical Entities. — In case any violation of the Act is
committed by a partnership, corporation, association or any juridical entity, the
partner, president, director, manager, trustee, estate administrator, or officer whoconsents to or knowingly tolerates such violation shall be held criminally liable as a
co-principal.
The penalty provided for the offense under the Act shall be imposed upon the
partner, president, director, manager, trustee, estate administrator, or officer who
knowingly authorizes, tolerates or consents to the use of a vehicle, vessel, aircraft,
equipment or other facility, as an instrument in the importation, sale, trading,
administration, dispensation, delivery, distribution, transportation or manufacture of
dangerous drugs, or chemical diversion, if such vehicle, vessel, aircraft, equipment
or other instrument is owned by or under the control or supervision of the
partnership, corporation, association or juridical entity to which they are affiliated.
SECTION 31. Additional Penalty If Offender is an Alien. — In addition to the
penalties prescribed in the unlawful act committed, any alien who violates such
provisions of the Act shall, after service of sentence, be deported immediately
without further proceedings, unless the penalty is death.
SECTION 32. Liability of a Person Violating Any Regulation Issued by the Board.
— The penalty of imprisonment ranging from six (6) months and one (1) day to four
(4) years and a fine ranging from Ten thousand pesos (P10,000.00) to Fifty thousand
pesos (P50,000.00) shall be imposed upon any person found violating any regulation
duly issued by the Board pursuant to the Act, in addition to the administrative
sanctions imposed by the Board.
SECTION 33. Immunity from Prosecution and Punishment. — Notwithstanding
the provisions of Section 17, Rule 119 of the Revised Rules of Criminal Procedure
and the provisions of Republic Act No. 6981 or the Witness Protection, Security and
Benefit Act of 1991, any person who has violated Sections 7, 11, 12, 14, 15 and 19,
Article II of the Act, who voluntarily gives information about any violation of
Sections 4, 5, 6, 8, 10, 13 and 16; Article II of the Act, as well as any commission of
the offenses mentioned if or committed by a drug syndicate, or any information
leading to the whereabouts, identities and arrest of all or any of the members thereof;
and who willingly testifies against such person as described above, shall be
exempted from prosecution or punishment for the offense with reference to which
his/her information and testimony were given, and may plead or prove the giving of
such information and testimony in bar of such prosecution: Provided, that the
following conditions concur:
a. The information and testimony are necessary for the conviction of
the persons described above;
b. Such information and testimony are not yet in the possession of
the State;
c. Such information and testimony can be corroborated on its
material points;
d. The informant or witness has not been previously convicted of a
crime involving moral turpitude, except when there is no other direct
evidence available for the State other than the information and testimony
of said informant or witness; ande. The informant or witness shall strictly and faithfully comply
without delay, any condition or undertaking, reduced into writing,
lawfully imposed by the State as further consideration for the grant of
immunity from prosecution and punishment.
Provided, further, that this immunity may be enjoyed by such informant or witness
who does not appear to be most guilty for the offense with reference to which his/her
information or testimony were given; Provided, finally, that there is no direct
evidence available for the State except for the information and testimony of the said
informant or witness.
SECTION 34. Termination of the Grant of Immunity. — The immunity granted to
the informant or witness, as prescribed in Section 33 of the Act, shall not attach
should it turn out subsequently that the information and/or testimony is false,
malicious or made only for the purpose of harassing, molesting or in any way
prejudicing the persons described in the preceding Section against whom such
information or testimony is directed. In such case, the informant or witness shall be
subject to prosecution and the enjoyment of all rights and benefits previously
accorded him under the Act or any other law, decree or order shall be deemed
terminated.
In case an informant or witness under the Act fails or refuses to testify without just
cause, and when lawfully obliged to do so, or should he/she violate any condition
accompanying such immunity as provided above, his/her immunity shall be removed
and he/she shall likewise be subject to contempt and/or criminal prosecution, as the
case may be, and the enjoyment of all rights and benefits previously accorded him
under the Act or in any other law, decree or order shall be deemed terminated.
In case the informant or witness referred to under the Act falls under the
applicability of this Section hereof, such individual cannot avail of the provisions
under Article VIII of the Act.
SECTION 35. Accessory Penalties. — A person convicted under the Act shall be
disqualified to exercise his/her civil rights such as, but not limited to, the rights of
parental authority or guardianship, either as to the person or property of any ward,
the rights to dispose of such property by any act or any conveyance inter vivos, and
political rights such as, but not limited to, the right to vote and be voted for. Such
rights shall also be suspended during the pendency of an appeal from such
conviction.
ARTICLE III
Dangerous Drugs Test and Record Requirements
SECTION 36. Authorized Drug Testing. — Authorized drug testing shall be done
by any government forensic laboratory or by any of the drug testing laboratories
accredited and monitored by the DOH to safeguard the quality of test results. The
DOH shall take steps in setting the price of the drug test with DOH accredited drug
testing centers to further reduce the cost of such drug test. The drug testing shall
employ, among others, two (2) testing methods, the screening test which will
determine the positive result as well as the type of the drug used and the
confirmatory test which will confirm a positive screening test. Drug test certificates
issued by accredited drug testing centers shall be valid for a one-year period fromthe date of issue which may be used for other purposes. The following shall undergo
drug testing:
a. Applicants for driver's license. — No driver's license shall be
issued or renewed to any person unless he/she presents a certification that
he/she has undergone a mandatory drug test and indicating thereon that
he/she is free from the use of dangerous drugs: Provided, that the Land
Transportation Office shall see to it that no driver's license is issued
without a drug test certificate indicating that the applicant is drug-free;
Provided, further, that all drug testing expenses will be borne by these
licensees;
b. Applicants for firearm's license and for permit to carry firearms
outside of residence. — All applicants for firearm's license and permit to
carry firearms outside of residence shall undergo a mandatory drug test
to ensure that they are free from the use of dangerous drugs: Provided,
that all persons who by the nature of their profession carry firearms shall
undergo drug testing; Provided, further, that the Philippine National
Police shall ensure that no firearm's license or permit is issued without a
drug test certificate indicating that the applicant is drug-free; Provided,
finally, that all drug testing expenses will be borne by said licensees and
permittees;
c. Students of tertiary and secondary schools. — Students of tertiary
and secondary schools shall, pursuant to the related rules and regulations
as contained in the school's student handbook and with notice to the
parents, undergo a random drug testing: Provided, that all drug testing
expenses whether in public or private schools under this Section will be
borne by the government; Provided, further, that the Department of
Education and the Commission on Higher Education, as the case may be,
shall see to it that this provision is implemented;
d. Officers and employees of public and private offices. — Officers
and employees of public and private offices, whether domestic or
overseas, shall undergo a random drug test as contained in the company's
work rules and regulations, which shall be borne by the employer, for
purposes of reducing the risk in the workplace. Any officer or employee,
found positive for use of dangerous drugs shall be dealt with
administratively which shall be a ground for suspension or termination,
subject to the provisions of Article 282 of the Labor Code and pertinent
provisions of the Civil Service Law: Provided, that the Department of
Labor and Employment and the Civil Service Commission, as the case
may be, shall see to it that this provision is implemented;
e. Officers and members of the military, police and other law
enforcement agencies. — Officers and members of the military, police
and other law enforcement agencies shall undergo an annual mandatory
drug test: Provided, that the respective heads of these agencies shall see
to it that this provision is implemented;
f. All persons charged before the prosecutor's office with a criminal
offense having an imposable penalty of imprisonment of not less than six(6) years and one (1) day shall have to undergo a mandatory drug test:
Provided, that the National Prosecution Office shall see to it that this
provision is implemented by requiring the apprehending unit to have the
persons charged drug-tested; Provided, further, that all drug testing
expenditures will be borne by the government, subject to the guidelines
to be issued by the Board; and
g. All candidates for public office whether appointed or elected both
in the national or local government shall undergo mandatory drug test:
Provided, that the Commission on Elections and the Civil Service
Commission, as the case may be, shall see to it that this provision is
implemented; Provided, further, that the concerned candidates will bear
all the drug testing expenditures.
In addition to the above stated penalties in this Section, those found to be positive
for dangerous drug use shall be subject to the provisions of Section 15 of the Act.
The DOH shall be the sole drug-testing licensing/accrediting body of the
government to the exclusion of all other agencies. It shall be responsible for setting
the standards and guidelines of operations of these facilities, as well as the
monitoring of the implementations thereof.
SECTION 37. Issuance of False or Fraudulent Drug Test Results. — Any person
authorized, licensed or accredited under the Act and its implementing rules and to
conduct drug examination or test, who issues false or fraudulent drug test results
knowingly, willfully or through gross negligence, shall suffer the penalty of
imprisonment ranging from six (6) years and one (1) day to twelve (12) years and a
fine ranging from One hundred thousand pesos (P100,000.00) to Five hundred
thousand pesos (P500,000.00).
An additional penalty shall be imposed through the revocation of the license to
practice his/her profession in case of a practitioner; and the closure of the drug
testing center.
SECTION 38. Laboratory Examination or Test on Apprehended/Arrested
Offenders. — Subject to Section 15 of the Act, any person apprehended or arrested
for violating the provisions of the Act shall be subjected to screening laboratory
examination or test within twenty-four (24) hours; if the apprehending or arresting
officer has reasonable ground to believe that the person apprehended or arrested, on
account of physical signs or symptoms or other visible or outward manifestation, is
under the influence of dangerous drugs. If found to be positive, the results of the
screening laboratory examination or test shall be challenged within fifteen (15) days
after receipt of the result through a confirmatory test conducted in any accredited
analytical laboratory equipped with a gas chromatograph/mass spectrometry
equipment or some such modern and accepted method, and if confirmed, the same
shall be prima facie evidence that such person has used dangerous drugs, which is
without prejudice for the prosecution for other violations of the provisions of the
Act: Provided, that a positive screening laboratory test must be confirmed for it to be
valid in court of law.
SECTION 39. Accreditation of Drug Testing Centers and Physicians. — The DOH
shall be tasked to license and accredit drug testing centers in each province and cityin order to assure their capacity, competence, integrity and stability, to conduct the
laboratory examinations and tests provided in this Article, and appoint such
technical and other personnel as may be necessary for the effective implementation
of this provision. The DOH shall also accredit physicians who shall conduct the
drug dependency examination of a drug dependent, as well as the after-care and
follow-up program for the said drug dependent. There shall be a control regulations,
licensing and accreditation division under the supervision of the DOH for this
purpose.
For this purpose, the DOH shall establish, operate and maintain drug testing centers
in government hospitals, which must be provided at least with basic technologically
advanced equipment and materials, in order to conduct the laboratory examinations
and tests herein provided, and appoint such qualified and duly trained technical and
other personnel as may be necessary for the effective implementation of this
provision.
The DOH, in coordination with the DDB, shall issue Orders, Memoranda or
Circulars providing for the implementing guidelines and specific technical
requirements related to licensing and accreditation.
SECTION 40. Records Required for Transactions on Dangerous Drugs and
Precursors and Essential Chemicals. —
a. Every pharmacist dealing in dangerous drugs and/or controlled
precursors and essential chemicals shall maintain and keep an original
record of sales, purchases, acquisitions and deliveries of dangerous
drugs, indicating therein the following information:
1. License number and address of the pharmacist;
2. Name, address and license of the manufacturer, importer
or wholesaler from whom the dangerous drugs have been
purchased;
3) Quantity and name of the dangerous drugs purchased or
acquired;
4. Date of acquisition or purchase;
5. Name, address and community tax certificate number of
the buyer;
6. Serial number of the prescription and the name of the
physician, dentist, veterinarian or practitioner issuing the
same;
7. Quantity and name of the dangerous drugs sold or
delivered; and
8. Date of sale or delivery.A certified true copy of such record covering a period of six (6) months, duly signed
by the pharmacist or the owner of the drugstore, pharmacy or chemical
establishment, shall be forwarded to the Board within fifteen (15) days following the
last day of June and December of each year, with a copy thereof furnished the city or
municipal health officer concerned.
b. A physician, dentist, veterinarian or practitioner authorized to prescribe any
dangerous drug shall issue the prescription therefor in one (1) original and two (2)
duplicate copies. The original, after the prescription has been filled, shall be retained
by the pharmacist for a period of one (1) year from the date of sale or delivery of
such drug. One (1) copy shall be retained by the buyer or by the person to whom the
drug is delivered until such drug is consumed, while the second copy shall be
retained by the person issuing the prescription.
For purposes of the Act, all prescriptions issued by physicians, dentists, veterinarians
or practitioners shall be written on forms exclusively issued by and obtainable from
the DOH. Such forms shall be made of a special kind of paper and shall be
distributed in such quantities and contain such information and other data as the
DOH may, by rules and regulations, require. Such forms shall only be issued by the
DOH through its authorized employees to licensed physicians, dentists, veterinarians
and practitioners in such quantities as the Board may authorize. In emergency cases,
however, as the Board may specify in the public interest, a prescription need not be
accomplished on such forms. The prescribing physicians, dentists, veterinarians or
practitioner shall, within three (3) days after issuing such prescription, inform the
DOH of the same in writing. No prescription once served by the drugstore or
pharmacy be reused nor any prescription once issued be refilled.
c. All manufacturers, wholesalers, distributors, importers, dealers and retailers
of dangerous drugs and/or controlled precursors and essential chemicals shall keep a
record of all inventories, sales, purchases, acquisitions and deliveries of the same as
well as the names, addresses and licenses of the persons from whom such items were
purchased or acquired or to whom such items were sold or delivered, the name and
quantity of the same and the date of the transactions. Such records may be subjected
anytime for review by the Board.
ARTICLE IV
Participation of the Family, Students, Teachers and School Authorities in the
Enforcement of the Act
SECTION 41. Involvement of the Family. — The family being the basic unit of the
Filipino society shall be primarily responsible for the education and awareness of the
members of the family on the ill effects of dangerous drugs and close monitoring of
family members who may be susceptible to drug abuse.
a. The Family. — The family, particularly the parents, shall be
primarily responsible for promoting and strengthening the economic,
physical, social, emotional/psychological and spiritual well-being of each
member in order to develop it into a healthy, strong and stable one.
b. Family Solidarity. — Family solidarity shall be promoted through
family rituals such as praying together and reunions, family hour forsharing experiences, hobbies and other family life enrichment activities
to enhance cohesiveness, bonding and harmonious relationships among
its members.
c. Family Drug Abuse Prevention Program. — The family is the
best defense against drug abuse. Therefore, the prevention of drug abuse
shall start within the family.
c.1) The Family Drug Abuse Prevention Program is a community-based
program of preparing families to protect their members against the
adverse effects of drug abuse.
c.2) The objectives of the program are as follows:
c.2.1) To raise awareness and educate families on the
ill effects of drug abuse;
c.2.2) To equip the families with parenting and life
skills towards a drug-free home; and
c.2.3) To organize and mobilize families to consolidate
efforts in support of the program and of families at risk.
c.3) The program shall adopt the following components among others:
c.3.1) Advocacy and Information Education on Drug
Abuse
c.3.1.1) Integrate modules on drug prevention in existing
parent education and family life programs and services;
c.3.2) Capability Building of Parents and Youth on the
Prevention of Dangerous Drugs
c.3.2.1) Conduct capability-building programs for families,
community leaders and service providers on health, socio-
cultural, psychological, legal and economic dimensions and
implications of the drug problem;
c.3.2.2) Conduct life skills and leadership training, peer
counseling and values education towards the promotion of a
positive lifestyle.
c.3.3) Social Mobilization
c.3.3.1) Organize and promote family councils as advocates
of drug abuse prevention;
c.3.3.2) Organize family peer support groups to strengthen
coping capability of families in handling drug-related
problems and issues.
c.3.4) Networking and Alliance Buildingc.3.4.1) Network and build alliance with anti-drug abuse
councils, and agencies/institutions handling drug abuse cases.
d. Adoption of the Program. — The Program shall be adopted by the
national government agencies (NGAs), local government units (LGUs),
non-government organizations (NGOs) and other concerned entities.
e. Monitoring and Evaluation. — The Program shall be monitored
and evaluated by the DSWD for enrichment.
SECTION 42. Student Councils and Campus Organizations. — All elementary,
secondary and tertiary schools' student councils and campus organizations shall
include in their activities a program for the prevention of and deterrence in the use of
dangerous drugs, and referral for treatment and rehabilitation of students for drug
dependence.
The student governments/councils and legitimate school organizations of all private
and public schools shall:
a. include dangerous drug abuse awareness and prevention in the
objectives, programs and projects provided for in their respective
Constitution and By-Laws;
b. have detailed plans of action of their projects duly approved, with
the implementation of the same, monitored and evaluated by the school
heads/teacher-advisers;
c. participate actively in drug abuse prevention programs and
training activities initiated by government organizations (GOs) and non-
government organizations (NGOs) in the community; as part of their
extension services/co-curricular activities;
d. implement programs/projects focused on, but not limited to,
information campaigns, peer counseling, life skills and leadership
trainings; and
e. coordinate with the school administration relative to the treatment
and rehabilitation of students with drug-related problems.
SECTION 43. School Curricula. — Instruction on drug abuse prevention and
control shall be integrated in the elementary, secondary and tertiary curricula of all
public and private schools, whether general, technical, vocational or agro-industrial
as well as in non-formal, informal and indigenous learning systems. Such
instructions shall include:
a) Adverse effects of the abuse and misuse of dangerous drugs on
the person the family, the school and the community;
b) Preventive measures against drug abuse;
c) Health, socio-cultural, psychological, legal and economic
dimensions and implications of the drug problem;d) Steps to take when intervention on behalf of a drug dependent is
needed, as well as the services available for the treatment and
rehabilitation of drug dependents; and
e) Misconceptions about the use of dangerous drugs such as, but not
limited to, the importance and safety of dangerous drugs for medical and
therapeutic use as well as the differentiation between medical patients
and drug dependents in order to avoid confusion and accidental
stigmatization in the consciousness of the students.
The Department of Education (DepEd) shall:
1. integrate drug abuse prevention concepts into such subjects as,
but not limited to, Science and Health and Makabayan at the elementary
level, and Science and Technology and Makabayan at the secondary
level;
2. integrate such concepts in the Non-Formal Education Program,
particularly functional education and literacy, continuing education and
values education;
3. continuously develop, update and adopt learning packages to
support the existing drug education concepts/contents in the textbooks
and other instructional materials;
4. support the National Drug Education Program (NDEP), with the
school head fully responsible for its effective implementation; and
5. mobilize the school health and nutrition personnel to supplement
and complement classroom instruction by communicating drug abuse
prevention messages to the students, teachers and parents.
The Commission on Higher Education (CHED) shall continue to enrich and update
the integration of dangerous drug prevention concerns, in the general education
components of all higher education course offerings, as well as in the professional
subjects particularly that of Health-related, other Science and Teacher Education
courses.
The Technical Education and Skills Development Authority (TESDA) shall:
1. integrate drug abuse prevention concepts in the technical,
vocational and agro-industrial courses; and
2. include such concepts in appropriate instructional materials for
technical education and skills development.
The DepEd, CHED and TESDA shall:
1. provide a continuing in-service training of teachers on the
effective utilization of the support instructional materials and on teaching
strategies on drug education;2. continuously monitor and evaluate the effectiveness of the overall
impact of the dangerous drug abuse prevention program through their
respective regional/field offices;
3. secure funds from local and foreign donor agencies for the
implementation of the drug education program whenever possible;
4. enlist the assistance of any government agency or instrumentality
to carry out the objectives of the education program; and
5. include the pertinent provisions of the Act as one of the major
topics of drug education in appropriate courses.
SECTION 44. Heads, Supervisors, and Teachers of Schools. — For the purpose of
enforcing the provisions of Article II of the Act, all school heads, supervisors and
teachers shall be deemed persons in authority and, as such, are hereby empowered to
apprehend, arrest or cause the apprehension or arrest of any person who shall violate
any of the said provisions, pursuant to Section 5, Rule 113 of the Rules of Court.
They shall be deemed persons in authority if they are in the school or within its
immediate vicinity, or even beyond such immediate vicinity if they are in attendance
at any school or class function in their official capacity as school heads, supervisors,
and teachers.
Any teacher or school employee, who discovers or finds that any person in the
school or within its immediate vicinity is liable for violating any of said provisions,
shall have the duty to report the same to the school head or immediate superior who
shall, in turn, report the matter to the proper authorities.
Failure to do so in either case, within a reasonable period from the time of discovery
of the violation shall, after due hearing, constitute sufficient cause for disciplinary
action by the school authorities.
a. The school heads, supervisors and teachers:
a.1) shall effect the arrest of any person violating Article II of the Act
inside the school campus and/or within its immediate vicinity or in other
places as provided for in Section 44 of the Act, and turn over the
investigation of the case to the PDEA;
a.2) may summon the services of other law enforcement agencies to
arrest or cause the apprehension or arrest of persons violating Article II
of the Act;
a.3) shall be trained on arrest and other legal procedures relative to the
conduct of arrest of violators of the Act along with student leaders and
Parents Teachers Association (PTA) officials; and
a.4) shall refer the students or any other violators found to be using
dangerous drugs to the proper agency/office.
(b) A Special Unit or Task Force from existing school personnel, student leaders
and PTA officials shall be organized in every school and trained to assist in theapprehension or arrest of violators of Article II of the Act within their areas of
jurisdiction.
(c) Appropriate protection of the concerned school officials shall be put in place to
ensure personal security and peace of mind among them, such as free legal
assistance, police protection and any other assistance as may be deemed necessary.
SECTION 45. Publication and Distribution of Materials on Dangerous Drugs. —
With the assistance of the Board, the Secretary of the Department of Education
(DepEd), the Chairperson of the Commission on Higher Education (CHED), and the
Director-General of the Technical Education and Skills Development Authority
(TESDA) shall cause the development, publication and distribution of information
and support educational materials on dangerous drugs to the students, the faculty, the
parents and the community.
(a) DepEd, CHED and TESDA shall develop and provide adequate
information materials on dangerous drug abuse and prevention;
(b) An Evaluation Committee composed of DepEd, CHED, TESDA,
DOH and DDB shall be organized, the main task of which, is to
determine the appropriateness of all instructional and information
materials to be used in schools; and
(c) DepEd, CHED and TESDA shall include drug abuse prevention
and control activities in their Manual of Regulations/Service Manual.
Schools, colleges and universities shall include information/guidelines on
drug abuse prevention and control in the Student's Handbook/Gabay sa
Mag-aaral and school publications/official organs.
SECTION 46. Special Drug Education Center. — With the assistance of the
Board, the Department of Interior and Local Government (DILG), the National
Youth Commission (NYC), and the Department of Social Welfare and Development
(DSWD) shall establish in each of its provincial office a special drug education
center for out-of-school youth and street children. Such Center which shall be
headed by the Provincial Social Welfare Development Officer shall sponsor drug
prevention programs and activities and information campaigns with the end in view
of educating the out-of-school youth and street children regarding the pernicious
effects of drug abuse. The programs initiated by the Center shall likewise be
adopted in all public and private orphanage and existing special centers for street
children.
a. The Establishment of Special Drug Education Center (SDEC)
a.1) A Special Drug Education Center for out-of-school youth and street children
shall be established in every province to be headed by a Provincial Social Welfare
Development Officer (PSWDO). The concerned Provincial Government shall
establish and maintain the center with the assistance of the Board, the DILG, the
NYC and the DSWD.
The SDEC in the province may serve the out-of-school youth and children in the
component cities and municipalities within its geographical coverage. However,highly urbanized and non-component cities shall be encouraged to establish their
own SDECS to carry out an effective drug education prevention program.
a.2) The SDEC may be established through any of the following manner:
a.2.1) As part of existing facilities of any government organization
(GO), non-government organization (NGO), civic, labor or religious
organization, or the private sector; or
a.2.2) As a new center constructed through government funds,
donations, grants and the like.
a.3) The Provincial Government shall provide the personnel, supplies, equipment
and others as it may deem necessary to carry out the effective implementation of a
preventive drug education program. The Board, DILG, NYC and DSWD shall
provide support in the operation of the SDEC.
b. Functions of the SDEC. — It shall exercise the following:
b.1) Develop and implement drug abuse prevention programs such as
community information and education activities on the ill effects of drug
abuse, literacy programs, skills and livelihood activities, among others,
for out-of-school youth, street children and their parents;
b.2) Conduct life skills and leadership training, peer counseling and
values education towards the promotion of a positive lifestyle;
b.3) Advocate local legislations, policies and programs, as well as
generate resources to support the SDEC;
b.4) Maintain a databank on out-of-school youth, street children and
young drug dependents; and
b.5) Establish linkages with anti-drug abuse councils, youth-serving
agencies, youth organizations, rehabilitation centers, after-care facilities
and other networks to ensure coordinated efforts in the prevention of
drug abuse;
c. Roles and Responsibilities of DILG, NYC and DSWD. — The following
agencies shall have their respective roles and responsibilities:
c.1) The Dangerous Drugs Board (DDB)
c.1.1) Develop a national prevention program, in cooperation with
the DILG, NYC and DSWD, designed for out-of-school youth and street
children.
c.1.2) Require the SDECs to submit periodic reports on their
activities pertaining to said program.
c.2) Department of Interior and Local Government (DILG)c.2.1) Assist and monitor the Provincial Government in order to
ensure the establishment of the SDEC;
c.2.2) Provide technical assistance on the operation and
management of the SDEC;
c.2.3) Establish linkages with local, national and international
agencies for technical and financial support to the SDEC; and
c.2.4) Monitor and ensure the submission of SDEC reports to the
Board.
c.3.) National Youth Commission
c.3.1) Conduct life skills training to the out-of-school youth, street
children and young drug dependents; and
c.3.2) Provide access to existing programs/services of NYC , such
as, but not limited to, Ship for Southeast Asian Youth Program, Youth
Entrepreneurship Program, and National Youth Parliament and
Government Internship Program.
c.4) Department of Social Welfare and Development (DSWD)
c.4.1) Provide technical assistance in the development of a drug
abuse prevention program;
c.4.2) Undertake training/capability building activities for center
staff;
c.4.3) Develop standards for the SDEC; and
c.4.4) Accredit SDEC and monitor its compliance with set
standards.
d. Programs of the SDEC. — The programs of the SDEC shall be
accredited by the DSWD and be adopted in all private and public
orphanages/child caring agencies and existing special centers whenever
applicable.
e. Appropriations. — The funds for the establishment and
maintenance of the SDEC shall be sourced out from the following:
e.1) Annual budget of the Local Social Welfare and Development
Office;
e.2) Development funds of the LGU subject to the approval of the
Sangguniang Panlalawigan; and
e.3) Other sources, such as, but not limited to, share from the Philippine
Amusement and Gaming Corporation (PAGCOR) and gaming and
amusement centers.ARTICLE V
Promotion of a National Drug-Free Workplace Program with the Participation
of Private and Labor Sectors and the Department of Labor and Employment
SECTION 47. Drug-Free Workplace. — It is deemed a policy of the State to
promote drug-free workplaces using a tripartite approach. With the assistance of the
Board, the Department of Labor and Employment (DOLE) shall develop, promote
and implement a national drug abuse prevention program in the workplace to be
adopted by private companies with ten (10) or more employees. Such program shall
include the mandatory drafting and adoption of company policies against drug use in
the workplace in close consultation and coordination with the DOLE, labor and
employer organizations, human resource development managers and other such
private sector organizations.
a. A National Drug-Free Workplace Abuse Prevention Program shall
be formulated by a tripartite Task Force composed of representatives
from the DOLE, workers' and employers' groups. It shall be supported
by the Board, other concerned government organizations (GOs), and
non-government organizations (NGOs).
b. The Secretary of the DOLE shall issue a Department Order
creating a Task Force consisting of tripartite and other agencies to
formulate policies and strategies for the purpose of developing a National
Action Agenda on drug abuse prevention in the workplace. Pursuant to
the declared policy of the State and the national workplace policy, the
DOLE shall issue a Department Order (DO) requiring all private
companies to adopt and implement drug abuse prevention programs in
the workplace, including the formulation of company policies.
c. Pursuant to the functions of the Board under Section 81 (a) of the
Act, the existing Civil Service rules and policies needed to respond to
drug abuse in the public sector shall be adopted.
SECTION 48. Guidelines for the National Drug-Free Workplace Program. — The
Board and the DOLE shall formulate the necessary guidelines for the
implementation of the national drug-free workplace program. The amount necessary
for the implementation of which shall be included in the annual General
Appropriations Act.
The Task Force shall develop a comprehensive National Drug-Free Workplace
Program in accordance with the following guidelines:
a. All private sector organizations with ten (10) or more personnel shall
implement a drug abuse prevention program.
a.1) The workplace program shall include advocacy and capability
building and other preventive strategies including but not limited to:
company policies, training of supervisors/managers, employee education,
random drug testing, employee assistance program and monitoring and
evaluation.a.2) The workplace program shall be integrated in the safety and health
programs.
b. DOLE and labor and employers' groups shall also encourage drug-free
policies and programs for private companies with nine (9) workers or less.
c. Any officer or employee found positive for use of dangerous drugs shall be
dealt with administratively which shall be a ground for suspension or termination,
subject to the provisions of Article 282 of Book VI of the Labor Code.
d. Private sector organizations may extend the drug education program to the
employees/personnel and immediate families to contribute in the promotion of a
healthy drug-free family, community and society.
e. All private sector organizations shall display in a conspicuous place a
billboard or streamer with a standard message of "THIS IS A DRUG-FREE
WORKPLACE: LET'S KEEP IT THIS WAY!" or such other messages of similar
import.
ARTICLE VI
Participation of the Private and Labor Sectors in the Enforcement of the Act
SECTION 49. Labor Organizations and the Private Sector. — All labor unions,
federations, associations; or organizations in cooperation with the respective private
sector partners shall include in their collective bargaining or any similar agreements,
joint continuing programs and information campaigns for the laborers similar to the
programs provided under Section 47 of the Act with the end in view of achieving a
drug-free workplace.
It shall be required that the workplace drug abuse prevention policies and programs
be included as part of the Collective Bargaining Agreement (CBA).
SECTION 50. Government Assistance. — The labor sector and the respective
partners may, in pursuit of the programs mentioned in the preceding Section, secure
the technical assistance, such as, but not limited to, seminars and information
dissemination campaigns of the appropriate government and law enforcement
agencies.
a. The DOLE, DDB, and PDEA and other government agencies
shall provide technical assistance in planning, developing, monitoring
and evaluating drug abuse prevention programs, including a referral
system for treatment and rehabilitation, in the labor sector both private
and public.
b. Workplace drug abuse prevention programs shall be included in
existing advocacy and capability building programs of the government.
c. The labor inspection arm of the DOLE shall develop an
appropriate inspection form to be integrated in the on-going general labor
standards inspection.d. The information and dissemination of pertinent provisions of the
Act and the IRR shall be included in the agenda of the advisory visits of
the labor enforcement advisory team.
ARTICLE VII
Participation of Local Government Units
SECTION 51. Local Government Units' Assistance. — The LGUs shall
appropriate a substantial portion of their respective annual budgets to assist in or
enhance the enforcement of the Act giving priority to preventive or educational
programs and the rehabilitation or treatment of drug dependents.
a. Consistent with the principles of local autonomy, the local sanggunians shall
appropriate substantial funds from their annual budgets to be utilized in assisting or
enhancing the enforcement of the Act, giving priority to educational programs on
drug abuse prevention and control and rehabilitation and treatment of drug
dependents, such amount to be determined by the sanggunian concerned based on
the perceived need of the locality.
b. As used in this Section, "perceived need" may cover such factors as, but not
limited to, the following:
b.1 Considerable increase in the number of drug dependents in the area;
b.2 The rise in drug-related crime incidents as certified to by the local
PNP and/or PDEA; and
b.3 The need for preventive and advocacy initiatives.
SECTION 52. Abatement of Drug Related Public Nuisances. — Any place or
premises which have been used on two or more occasions as the site of the unlawful
sale or delivery of dangerous drugs, or used as drug dens for pot sessions and other
similar activities, may be declared to be a public nuisance, and such nuisance may
be abated, pursuant to the following procedures:
a. Any city or municipality may, by ordinance, create an administrative board to
hear complaints regarding the nuisances, to be composed of the following:
a.1 City/Municipal Health Officer as chairperson;
a.2 City/Municipal Legal Officer as member, provided that in
cities/municipalities with no Legal Officer, the City/Municipal
Administrator shall act as member; and
a.3 The Local Chief of Police as member;
b. Any employee, officer, or resident of the city or municipality may bring a
complaint before the administrative board after giving not less than three (3) days
written notice of such complaint to the owner of the place or premises at his/her last
known address;
c. Within three (3) days from receipt of the complaint, a hearing shall then be
conducted by the administrative board, with notice to both parties, and theadministrative board may consider any evidence submitted, including evidence of
general reputation of the place or premises;
d. The owner/manager of the premises or place shall also be given an
opportunity to present any evidence in his/her defense;
e. After hearing, the administrative board may declare the place or premises to
be a public nuisance; and
f. The hearing shall be terminated within ten (10) days from commencement.
Subject to the limitation on personal services under the Local Government Code of
1991, the availability of funds and the existing Department of Budget and
Management (DBM) Local Budget Circulars, the Sangguniang Bayan/Panlungsod
may grant reasonable honoraria to the chairperson and members of the
administrative board.
SECTION 53. Effect of the Administrative Board Declaration. — If the
administrative board declares a place or premises to be a public nuisance, it shall
issue an order immediately prohibiting the conduct, operation or maintenance of any
business or activity on the premises which is conducive to such nuisance. The
city/municipal mayor shall implement the order of the administrative board and shall
assume full responsibility in seeing to it that the order is immediately complied with.
The order issued by the administrative board shall expire after one (1) year, or at
such an earlier time as stated in the order. The administrative board may bring a
complaint seeking a permanent injunction against any nuisance described under this
IRR.
The administrative board, upon showing that the place is no longer a public
nuisance, may conduct hearing with the complainant duly notified, for the possible
lifting of the order.
The DDB shall issue guidelines on the proper implementation of the order of the
administrative board in case the place or premises declared as a public nuisance is a
residential house, without prejudice to the filing of criminal case against the owner
of the house pursuant to Section 6 of the Act.
This IRR does not restrict the right of any person to proceed under the Civil Code on
public nuisance. Neither shall this restrict the power of the Sangguniang Bayan and
Sangguniang Panlungsod per Section 447 [a] [4] [i] and Section 458 [a] [4] [i],
respectively, of the Local Government Code, to declare or abate any nuisance.
ARTICLE VIII
Program for Treatment and Rehabilitation of Drug Dependents
SECTION 54. Voluntary Submission of a Drug Dependent to Confinement,
Treatment and Rehabilitation. — A drug dependent or any person who violates
Section 15 of the Act may, by himself/herself or through his/her parent, spouse,
guardian or relative within the fourth degree of consanguinity or affinity, apply to
the Board or its duly recognized representative, for treatment and rehabilitation ofthe drug dependency. Upon such application, the Board shall bring forth the matter
to the court which shall order that the applicant be examined for drug dependency.
If the examination by a DOH-accredited physician results in the issuance of a
certification that the applicant is a drug dependent, he/she shall be ordered by the
court to undergo treatment and rehabilitation in a Center designated by the Board for
a period of not less than six (6) months: Provided, that a drug dependent may be
placed under the care of a DOH-accredited physician where there is no Center near
or accessible to the residence of the drug dependent or where said drug dependent is
below eighteen (18) years of age and is a first-time offender and non-confinement in
a Center will not pose a serious danger to his/her family or community.
Confinement in a Center for treatment and rehabilitation shall not exceed one (1)
year, after which time the court, as well as the Board, shall be apprised by the head
of the treatment and rehabilitation center of the status of said drug dependent and
determine whether further confinement will be for the welfare of the drug dependent
and his/her family or the community.
The DOH, in consultation with the DDB, shall provide standards and guidelines for
the accreditation of the physicians.
SECTION 55. Exemption from the Criminal Liability Under the Voluntary
Submission Program. — A drug dependent under the voluntary submission program,
who is finally discharged from confinement, shall be exempt from the criminal
liability under Section 15 of the Act subject to the following conditions:
a. He/she has complied with the rules and regulations of the Center,
the applicable rules and regulations of the Board, including the after-care
and follow-up program for at least eighteen (18) months following
temporary discharge from confinement in the Center or, in the case of a
drug dependent placed under the care of the DOH-accredited physician,
the after-care program and follow-up schedule formulated by the DSWD
and approved by the Board: Provided, that capability-building of local
government social workers shall be undertaken by the DSWD;
b. He/she has never been charged or convicted of any offense
punishable under the Act, the Dangerous Drugs Act of 1972 or Republic
Act No. 6425, as amended; the Revised Penal Code, as amended; or any
special penal laws;
c. He/she has no record of escape from a Center: Provided, that had
he/she escaped, he/she surrendered by himself/herself or through his/her
parent; spouse, guardian or relative within the fourth degree of
consanguinity or affinity, within one (1) week from the date of the said
escape; and
d. He/she poses no serious danger to himself/herself, his/her family
or the community by his/her exemption from criminal liability.
SECTION 56. Temporary Release From the Center, After-Care and Follow-up
Treatment Under the Voluntary Submission Program. — Upon certification of the
enter that the drug dependent within the voluntary submission program may be
temporarily release the court shall order his/her release on condition that said drugdependent shall report to the DOH for after-care and follow-up treatment, including
urine testing, for a period not exceeding eighteen (18) months under such terms and
conditions that the court may impose.
If during the period of after-care and follow-up, the drug dependent is certified to be
rehabilitated, he/she may be discharged by the court, subject to the provisions of
Section 55 of the Act, without prejudice to the outcome of any pending case filed in
court.
However, should the DOH find that during the initial after-care and follow-up
program of eighteen (18) months, the drug dependent requires further treatment and
rehabilitation in the Center, he/she shall be recommitted to the Center for
confinement. Thereafter, he/she may again be certified for temporary release and
ordered released for another after-care and follow-up program pursuant to this
Section.
The DOH shall formulate standards and guidelines, in consultation with the DDB,
after-care and follow-up, treatment wherein the following provisions, among others,
shall be incorporated:
a. The DOH-accredited physician can recommend to the court the
release of a drug dependent at least forty-five (45) days after initial
admission to a facility; and
b. The physician should likewise prescribe a comprehensive after-
care and follow-up program which the dependent should adhere to in
order to complete at least eighteen (18) months, depending on the
assessment and evaluation of the physician and subject to the approval of
the court.
SECTION 57. Probation and Community Service Under the Voluntary Submission
Program. — A drug dependent who is discharged as rehabilitated by the DOH-
accredited Center through the voluntary submission program, but does not qualify
for exemption from criminal liability under Section 55 of the Act, may be charged
under the provisions of the Act, but shall be placed on probation and undergo
community service in lieu of imprisonment and/or fine in the discretion of the court,
without prejudice to the outcome of any pending case filed in court.
Such drug dependent shall undergo community service as part of his/her after-care
and follow-up program, which may be done in coordination with non-government,
civic organizations accredited by the DSWD, with the recommendation of the
Board.
SECTION 58. Filing of Charges Against a Drug Dependent Who is Not
Rehabilitated Under the Voluntary Submission Program. — A drug dependent who
is not rehabilitated after the second commitment to the Center under the voluntary
submission program, shall, upon recommendation of the Board, be charged with
violation of Section 15 of the Act and prosecuted like any other offender. If
convicted, he/she shall be credited for the period of confinement and rehabilitation
in the Center in the service of his/her sentence.SECTION 59. Escape and Recommitment for Confinement and Rehabilitation
Under the Voluntary Submission Program. — Should a drug dependent under the
voluntary submission program escape from the Center, he/she may submit
himself/herself for recommitment within one (1) week therefrom, or his/her parent,
spouse, guardian or relative within the fourth degree of consanguinity or affinity
may, within said period, surrender him for recommitment, in which case the
corresponding order shall be issued by the Board.
Should the escapee fail to submit himself/herself or be surrendered after one (1)
week, the Board shall apply to the court for a recommitment order. Upon proof of
previous commitment or his/her voluntary submission by the Board, the court may
issue an order for recommitment within one (1) week.
If, subsequent to a recommitment, the dependent once again escapes from
confinement, he/she shall be charged with violation of Section 15 of the Act and be
subjected under Section 61 of the Act, either upon order of the Board or upon order
of the court, as the case may be.
SECTION 60. Confidentiality of Records Under the Voluntary Submission
Program. — Judicial and medical records of drug dependents under the voluntary
submission program shall be confidential and shall not be used against him/her for
any purpose, except to determine how many times, by himself/herself or through
his/her parent, spouse, guardian or relative within the fourth degree of consanguinity
or affinity, he/she voluntarily submitted himself/herself for confinement, treatment
and rehabilitation or has been committed to a Center under this program.
However, where the drug dependent is not exempt from criminal liability under
Section 55 of the Act, or when he/she is not rehabilitated under the voluntary
submission program, or when he/she escapes again from confinement after
recommitment, the records mentioned in the immediately preceding provisions,
which are necessary of his/her conviction, may be utilized as evidence in court
against him/her..
SECTION 61. Compulsory Confinement of a Drug Dependent Who Refuses to
Apply Under the Voluntary Submission Program. — Notwithstanding any law, rule
and regulation to the contrary, any person determined and found to be dependent on
dangerous drugs shall, upon petition by the Board or any of its authorized
representatives, be confined for treatment and rehabilitation in any Center duly
designated or accredited for the purpose.
A petition for the confinement of a person alleged to be dependent on dangerous
drugs to a Center may be filed by any person authorized by the Board with the
Regional Trial Court of the province or city where such person is found.
After the petition is filed, the court, by an order, shall immediately fix a date for the
hearing, and a copy of such order shall be served on the person alleged to be
dependent on dangerous drugs, and to the one having charge of him/her.
If, after such hearing and the facts so warrant, the court shall order the drug
dependent to be examined by two (2) physicians accredited by the Board. If both
physicians conclude that the respondent is not a drug dependent, the court shall
order his/her discharge. If either physician finds him to be a dependent, the courtshall conduct a hearing and consider all relevant evidence which may be offered. If
the court finds him/her a drug dependent, it shall issue an order for his/her
commitment to a treatment and rehabilitation center under the supervision of the
DOH. In any event, the order of discharge or order of confinement or commitment
shall be issued not later than fifteen (15) days from the filing of the appropriate
petition.
SECTION 62. Compulsory Submission of a Drug Dependent Charged with an
Offense to Treatment and Rehabilitation. — If a person charged with an offense
where the imposable penalty is imprisonment of less than six (6) years and one (1)
day, and is found by the prosecutor or by the court at any stage of the proceedings, to
be a drug dependent, the prosecutor or the court as the case may be, shall suspend all
further proceedings and transmit copies of the record of the case to the Board.
In the event the Board determines, after medical examination, that public interest
requires that such drug dependent be committed to a center for treatment and
rehabilitation, it shall file a petition for his/her commitment with the regional trial
court of the province or city where he/she is being investigated or tried: Provided,
that where a criminal case is pending in court, such petition shall be filed in the said
court. The court shall take judicial notice of the prior proceedings in the case and
shall proceed to hear the petition. If the court finds him to be a drug dependent, it
shall order his/her commitment to a Center for treatment and rehabilitation. The
head of said Center shall submit to the court every four (4) months, or as often as the
court may require, a written report on the progress of the treatment. If the dependent
is rehabilitated, as certified by the Center and the Board, he/she shall be returned to
the court, which committed him, for his/her discharge therefrom.
Thereafter, his/her prosecution for any offense punishable by law shall be instituted
or shall continue, as the case may be. In case of conviction, the judgment shall, if the
accused is certified by the treatment and rehabilitation center to have maintained
good behavior, indicate that he/she shall be given full credit for the period he/she
was confined in the Center: Provided, however, that when the offense is for violation
of Section 15 of the Act and the accused is not a recidivist, the penalty thereof shall
be deemed to have been served in the Center upon his/her release therefrom after
certification by the Center and the Board that he/she is rehabilitated.
SECTION 63. Prescription of the Offense Charged Against a Drug Dependent
Under the Compulsory Submission Program. — The period of prescription of the
offense charged against a drug dependent under the compulsory submission program
shall not run during the time that the drug dependent is under confinement in a
Center or otherwise under the treatment and rehabilitation program approved by the
Board.
Upon certification of the Center that he/she may temporarily be discharged from the
said Center, the court shall order his/her release on condition that he/she shall report
to the Board through the DOH for after-care and follow-up treatment for a period not
exceeding eighteen (18) months under such terms and conditions as may be imposed
by the Board.
If at anytime during the after-care and follow-up period, the Board certifies to
his/her complete rehabilitation, the court shall order his/her final discharge from
confinement and order for the immediate resumption of the trial of the case forwhich he/she is originally charged. Should the Board through the DOH find at
anytime during the after-care and follow-up period that he/she requires further
treatment and rehabilitation, it shall report to the court, which shall order his/her
recommitment to the Center.
Should the drug dependent, having been committed to a Center upon petition by the
Board escape therefrom, he/she may resubmit himself/herself for confinement
within one (1) week from the date of his/her escape; or his/her parent, spouse;
guardian or relative within the fourth degree of consanguinity or affinity may, within
the same period, surrender him for recommitment. If, however, the drug dependent
does not resubmit himself/herself for confinement or he/she is not surrendered for
recommitment, the Board may apply with the court for the issuance of the
recommitment order. Upon proof of previous commitment, the court shall issue an
order for recommitment. If, subsequent to such recommitment, he/she should
escape again, he/she shall no longer be exempt from criminal liability for use of any
dangerous drug.
A drug dependent committed under this particular Section who is finally discharged
from confinement shall be exempt from criminal liability under Section 15 of the
Act, without prejudice to the outcome of any pending case filed in court. On the
other hand, a drug dependent who is not rehabilitated after a second commitment to
the Center shall, upon conviction by the appropriate court, suffer the same penalties
provided for under Section 15 of the Act, again without prejudice to the outcome of
any pending case filed in court.
SECTION 64. Confidentiality of Records Under the Compulsory Submission
Program. — The records of a drug dependent who was rehabilitated and discharged
from the Center under the compulsory submission program, or who was charged
with violation of Section 15 of the Act, shall be covered by Section 60 of the Act.
However, the records of a drug dependent who was not rehabilitated, or who escaped
but did not surrender himself/herself within the prescribed period, shall be
forwarded to the court and their use shall be determined by the court, taking into
consideration public interest and the welfare of the drug dependent.
SECTION 65. Duty of the Prosecutor in the Proceedings. — It shall be the duty of
the provincial or the city prosecutor or their assistants or state prosecutors to prepare
the appropriate petition in all proceedings arising from the Act.
SECTION 66. Suspension of Sentence of a First-Time Minor Offender. — An
accused who is over fifteen (15) years of age at the time of the commission of the
offense mentioned in Section 11 of the Act, but not more than eighteen (18) years of
age at the time when judgment should have been promulgated after having been
found guilty of said offense, may be given the benefits of a suspended sentence,
subject to the following conditions:
a. He/she has not been previously convicted of violating any
provision of the Act, or of the Dangerous Drugs Act of 1972, as
amended; or of the Revised Penal Code; or of any special penal taws;
b. He/she has not been previously committed to a Center onto the
care of a DOH-accredited physician; andc. The Board favorably recommends that his/her sentence be
suspended.
While under suspended sentence, he/she shall be under the supervision and
rehabilitative surveillance of the Board, under such conditions that the court may
impose for a period ranging from six (6) months to eighteen (18) months.
Upon recommendation of the Board, the court may commit the accused under
suspended sentence to a Center, or to the care of a DOH-accredited physician for at
least six (6) months, with after-care and follow-up program for not more than
eighteen (18) months.
In the case of minors under fifteen (15) years of age at the time of the commission of
any offense penalized under the Act, Article 192 of Presidential Decree No. 603,
otherwise known as the Child and Youth Welfare Code, as amended by Presidential
Decree No. 1179 shall apply, without prejudice to the application of the provisions
of this Section.
SECTION 67. Discharge After Compliance with Conditions of Suspended Sentence
of a First-Time Minor Offender. — If the accused first-time minor offender under
suspended sentence complies with the applicable rules and regulations of the Board,
including confinement in a Center, the court, upon favorable recommendation of the
Board for the final discharge of the accused shall discharge the accused and dismiss
all proceedings.
Upon the dismissal of the proceedings against the accused, the court shall enter an
order to expunge all official records, other than the confidential record to be retained
by the DOJ relating to the case. Such an order, which shall be kept confidential,
shall restore the accused to his/her status prior to the case. He/she shall not be held
thereafter to be guilty of perjury or of concealment or misrepresentation by reason of
his/her failure to acknowledge the case or recite any fact related thereto in response
to any inquiry made of him for any purpose.
SECTION 68. Privilege of Suspended Sentence to be Availed of Only Once by a
First-Time Minor Offender. — The privilege of suspended sentence shall be availed
of only once by an accused drug dependent who is a first-time offender over fifteen
(15) years of age at the time of the commission of the violation of Section 15 of the
Act but not more than eighteen (18) years of age at the time when judgment should
have been promulgated.
SECTION 69. Promulgation of Sentence for First-Time Minor Offender. — If the
accused first-time minor offender violates any of the conditions of his/her suspended
sentence, the applicable rules and regulations of the Board exercising supervision
and rehabilitative surveillance over him, including the rules and regulations of the
Center should confinement be required, the court shall pronounce judgment of
conviction and he/she shall serve sentence as any other convicted person.
SECTION 70. Probation or Community Service for a First-Time Minor Offender in
Lieu of Imprisonment. — Upon promulgation of the sentence, the court may, in its
discretion, place the accused under probation, even if the sentence provided under
the Act is higher than that provided under existing law on probation, or impose
community service in lieu of imprisonment. In case of probation, the supervisionand rehabilitative surveillance shall be undertaken by the Board through the DOH in
coordination with the Board of Pardons and Parole and the Probation
Administration. Upon compliance with the conditions of the probation, the Board
shall submit a written report to the court recommending termination of probation
and a final discharge of the probationer, whereupon the court shall issue such an
order.
The community service shall be complied with under conditions, time and place as
may be determined by the court in its discretion and upon the recommendation of
the Board and shall apply only to violators of Section 15 of the Act. The completion
of the community service shall be under the supervision and rehabilitative
surveillance of the Board during the period required by the court, Thereafter, the
Board shall render a report on the manner of compliance of said community service.
The court in its discretion may require extension of the community service or order a
final discharge.
In both cases, the judicial records shall be covered by the provisions of Sections 60
and 64 of the Act.
If the sentence promulgated by the court requires imprisonment, the period spent in
the Center by the accused during the suspended sentence period shall be deducted
from the sentence to be served.
SECTION 71. Records to be kept by the Department of Justice. — The DOJ shall
keep a confidential record of the proceedings on suspension of sentence and shall
not be used for any purpose other than to determine whether or not a person accused
under the Act is a first-time minor offender.
SECTION 72. Liability of a Person Who Violates the Confidentiality of Records.
— The penalty of imprisonment ranging from six (6) months and one (1) day to six
(6) years and a fine ranging from One thousand pesos (P1,000.00) to Six thousand
pesos (P6,000.00), shall be imposed upon any person who, having official custody of
or access to the confidential records of any drug dependent under voluntary
submission programs, or anyone who, having gained possession of said records,
whether lawfully or not, reveals their content to any person other than those charged
with the prosecution of the offenses under the Act and its implementation. The
maximum penalty shall be imposed, in addition to absolute perpetual
disqualification from any public office, when the offender is a government official or
employee. Should the records be used for unlawful purposes, such as blackmail of
the drug dependent or the members of his/her family, the penalty imposed for the
crime of violation of confidentiality shall be in addition to whatever crime he/she
may be convicted of.
SECTION 73. Liability of a Parent, Spouse or Guardian Who Refuses to
Cooperate with the Board or Any Concerned Agency. — Any parent, spouse or
guardian who, without valid reason, refuses to cooperate with the Board or any
concealed agency in the treatment and rehabilitation of a drug dependent who is a
minor, of in any manner, prevents or delays the after-care, follow-up or other
programs for the welfare of the accused drug dependent, whether under voluntary
submission program or compulsory submission program, may be cited for contempt
by the court.SECTION 74. Cost-Sharing in the Treatment and Rehabilitation of a Drug
Dependent. — The parent, spouse, guardian or any relative within the fourth degree
of consanguinity of any person who is confined under the voluntary submission
program or compulsory submission program shall be charged a certain percentage of
the cost of his/her treatment and rehabilitation, the guidelines of which shall be
formulated by the DSWD taking into consideration the economic status of the
family of person confined. The guidelines therein formulated shall be implemented
by a social worker of the local government unit.
a. Persons Sharing the Cost of Treatment and Rehabilitation of a Drug
Dependent. — The parent, spouse, guardian or any relative within the fourth degree
of consanguinity of any person who is confined under the voluntary submission
program or compulsory submission program shall share the cost of treatment and
rehabilitation of a drug dependent: Provided, however, that, in case a dependent has
no parent, spouse, guardian or relative within the fourth degree of consanguinity,
his/her rehabilitation shall be through the auspices of any government rehabilitation
center.
b. Factors in Determining Cost. — In government rehabilitation centers, the
following factors shall be taken into consideration in determining the share of the
cost:
b.1 Family income in relation to poverty threshold based on assessment
of the LGU social worker. Family income refers to the aggregate of
primary income, property income, pension and other current transfers
received by the immediate family or relatives of the drug dependent;
b.2 Capacity of the province/city/municipality based on their income
classification; and
b.3 The cost of treatment and rehabilitation based on a center's
facilities, programs and services.
c. Guiding Principles. — The following guiding principles shall be observed:
c.1 A family whose income is within poverty threshold shall be fully
subsidized by the government;
c.2 The higher the income of the family, the higher is its percentage
share;
c.3 The higher the capacity of the LGU, the better the quality of
programs, services and structures it shall provide;
c.4 Confidentiality of drug abuse cases shall be observed; and
c.5 Same quality of services shall be provided to both paying and non-
paying drug dependents.
d. Formulation of Cost Sharing Schedule. — Within sixty (60) days upon the
effectivity of this IRR, the respective provincial/city/municipal councils shall passan ordinance prescribing the cost-sharing percentage for the treatment and
rehabilitation of drug dependents.
SECTION 75. Treatment and Rehabilitation Centers. — The existing treatment
and rehabilitation centers for drug dependents operated and maintained by the NBI
and the PNP shall be operated, maintained and managed by the DOH, in
coordination with other concerned agencies. For the purpose of enlarging the
network of centers, the Board, through the DOH, shall encourage, private Centers
which shall be eligible to receive grants, donations or subsidy from either
government or private sources. It shall also support the establishment of
government-operated regional treatment and rehabilitation centers depending upon
the availability of funds. The national government, through its appropriate agencies
shall give priority funding for the increase of subsidy to existing government drug
rehabilitation centers, and shall establish at least one (1) rehabilitation center in each
province, depending on the availability of funds.
To ensure proper treatment and rehabilitation of drug dependents, the DOH shall
perform the following:
a. Formulate standards and guidelines for the operation and
maintenance of all treatment and rehabilitation centers nationwide;
b. Develop a system for monitoring and supervision of all drug
rehabilitation centers nationwide;
c. Create programs which will advocate for the establishment of
LGU-assisted rehabilitation facilities in each province;
d. Submit to the Department of Budget and Management (DBM) a
budget for the establishment, and operation of drug rehabilitation centers;
and
e. Facilitate the turn-over of all the rehabilitation centers from the
PNP and NBI thru a Memorandum of Agreement that shall be signed
within sixty (60) days after approval of this IRR.
SECTION 76. The Duties and Responsibilities of the Department of Health (DOH)
Under the Act. — The DOH shall:
a. Oversee and monitor the integration, coordination and
supervision of all drug rehabilitation, intervention, after-care and follow-
up programs, projects and activities, as well as the establishment,
operations, maintenance and management of privately-owned drug
treatment rehabilitation centers and drug testing networks and
laboratories throughout the country, in coordination with the DSWD and
other agencies;
b. License, accredit, establish and maintain drug test network and
laboratory; and initiate, conduct and support scientific research on drugs
and drug control;c. Encourage, assist and accredit private centers; and promulgate
rules and regulations setting minimum standards for their accreditation to
assure their competence, integrity and stability;
d. Prescribe and promulgate rules and regulations governing the
establishment of such Centers as it may deem necessary after conducting
a feasibility study thereof;
e. The DOH shall, without prejudice to the criminal prosecution of
those found guilty of violating the Act, order the closure of a Center for
treatment and rehabilitation of drug dependency when, after investigation
it is found guilty of violating the provisions of the Act or regulations
issued by the Board; and
f. Charge reasonable fees for drug dependency examinations, other
medical and legal services provided to the public, which shall accrue to
the Board. All income derived from these sources shall be part of the
funds constituted as special funds for the implementation of the Act
under Section 87.
ARTICLE IX
Dangerous Drugs Board and Philippine Drug Enforcement Agency
SECTION 77. The Dangerous Drugs Board. — The Board shall be the policy-
making and strategy-formulating body in the planning and formulation of policies
and programs on drug prevention and control. It shall develop and adopt a
comprehensive integrated, unified and balanced national drug abuse prevention and
control strategy. It shall be under the Office of the President.
SECTION 78. Composition of the Board. — The Board shall be composed of
seventeen (17) members wherein three (3) of which are permanent members, the
other; twelve (12) members shall be in an ex-officio capacity and the two (2) shall
be regular members.
The three (3) permanent members, who shall possess at least seven-year training and
experience in the field of dangerous drugs and in any of the following fields: law,
medicine, criminology, psychology or social work, shall be appointed by the
President of the Philippines. The President shall designate a Chairperson, who shall
have the rank of a secretary from among the three (3) permanent members who shall
serve for six (6) years and until their successors shall have been duly appointed and
qualified.
The other twelve (12) members who shall be ex-officio members of the Board are
the following:
1) Secretary of the Department of Justice or his/her representative;
2) Secretary of the Department of Health or his/her representative;
3) Secretary of the Department of National Defense or his/her
representative;4) Secretary of the Department of Finance or his/her representative;
5) Secretary of the Department of Labor and Employment or his/her
representative;
6) Secretary of the Department of the Interior and Local Government
or his/her representative;
7) Secretary of the Department of Social Welfare and Development or
his/her representative;
8) Secretary of the Department of Foreign Affairs or his/her
representative;
9) Secretary of the Department of Education or his/her representative;
10) Chairperson of the Commission on Higher Education or his/her
representative;
11) Chairperson of the National Youth Commission; and
12) Director General of the Philippine Drug Enforcement Agency.
Cabinet secretaries who are members of the Board may designate their duly
authorized and permanent representative whose ranks shall in no case be lower than
undersecretary.
The two (2) regular members shall be as follows:
a) The president of the Integrated Bar of the Philippines; and
b) The chairperson or president of a non-government organization
involved in dangerous drug campaign to be appointed by the President of
the Philippines.
The Director of the NBI and the Chief of the PNP shall be the permanent consultants
of the Board, and shall attend all the meetings of the Board.
All members of the Board, as well as its permanent consultants, shall receive a per
diem for every meeting actually attended subject to the pertinent budgetary laws,
rules and regulations on compensation, honoraria and allowances: Provided, that
where the representative of an ex-officio member or of the permanent consultant of
the Board attends a meeting in behalf of the latter, such representative shall be
entitled to receive the per diem.
SECTION 79. Meetings of the Board. — The Board shall meet once a week or
more frequently as necessary at the discretion of the Chairperson or at the call of any
four (4) other members. The presence of nine (9) members shall constitute a
quorum.
SECTION 80. Secretariat of the Board. — The Board shall recommend to the
President of the Philippines the appointment of an Executive Director, with the rank
of an undersecretary, who shall be the Secretary of the Board and administrativeofficer of its secretariat, and shall perform such other duties that may be assigned to
him/her. He/she must possess adequate knowledge, training and experience in the
field of dangerous drugs, and in any of the following fields: law enforcement, law,
medicine, criminology, psychology or social work.
Two deputy executive directors, for administration and operations, with the ranks of
assistant secretary, shall be appointed by the President upon recommendation of the
Board. They shall possess the same qualifications as those of the executive director.
They shall receive a salary corresponding to their position as prescribed by the
Salary Standardization Law as a Career Service Officer.
The existing secretariat of the Board shall be under the administrative control and
supervision of the Executive Director. It shall be composed of the following
Services: Policy Studies, Research and Statistics; Preventive Education, Training
and Information; Legal Affairs; and Administrative and Financial Management.
SECTION 81. Powers and Duties of the Board. — The Board shall:
a) Formulate, develop and establish a comprehensive, integrated,
unified and balanced national drug abuse prevention and control strategy;
b) Promulgate such rules and regulations as may be necessary to
carry out the purposes of the Act, including the manger of safekeeping,
disposition, burning or condemnation of any dangerous drug and/or
controlled precursor and essential chemical under the charge and custody
of DDB, PDEA and other concerned agencies, and prescribe
administrative remedies or sanctions for the violations of such rules and
regulations;
c) Conduct policy studies, program monitoring and evaluations and
other researches on drug prevention, control and enforcement;
d) Initiate, conduct and support scientific, clinical, social,
psychological, physical and biological researches on dangerous drugs
and dangerous drugs prevention and control measures;
e. Develop an educational program and information drive on the
hazards and prevention of illegal use of any dangerous drug and/or
controlled precursor and essential chemical based on factual data, and
disseminate the same to the general public, for which purpose the Board
shall endeavor to make the general public aware of the hazards of any
dangerous drug and/or controlled precursor and essential chemical by
providing among others, literature, films, displays or advertisements and
by coordinating with all institutions of learning, as well as with all
national and local enforcement agencies, in planning and conducting its
educational campaign programs to be implemented by the appropriate
government agencies;
f. Conduct continuing seminars for, and consultations with, and
provide information materials to judges and prosecutors in coordination
with the Office of the Court Administrator, in the case of judges, and the
DOJ, in the case of prosecutors, which aim to provide them with thecurrent developments and programs of the Board pertinent to its
campaign against dangerous drugs and its scientific researches on
dangerous drugs, its prevention and control measures;
g. Design special trainings in order to provide law enforcement
officers, members of the judiciary, and prosecutors, school authorities
and personnel of centers with knowledge and know-how in dangerous
drugs and/or controlled precursors and essential chemicals control, in
coordination with the Supreme Court, to meet the objectives of the
national drug control programs;
h. Design and develop, in consultation and coordination with the
DOH, DSWD and other agencies involved in drugs control, treatment
and rehabilitation, both, public and private, a national treatment and
rehabilitation program for drug dependents including a standard after-
care and community service program for recovering drug dependents;
i. Design and develop, jointly with the DOLE and in consultation
with labor and employer groups, as well as non-government
organizations, a drug abuse prevention program in the workplace that
would include a provision for employee assistance programs for
emotionally-stressed employees;
j. Prescribe and promulgate rules and regulations governing the
establishment of such centers, networks and laboratories as deemed
necessary after conducting a feasibility study, in coordination with the
DOH and other government agencies;
k. Initiate and authorize closure proceedings against non-accredited
and/or substandard rehabilitation centers based on verified reports of
human rights violations, sub-human conditions, inadequate medical
training and assistance and excessive fees for implementation by the
PDEA;
In conjunction with sub-paragraphs (c), (d) and (e) of Section 76 and
sub-paragraphs (j) and (k) of Section 81, the DDB and the DOH shall
jointly promulgate standards and guidelines for the establishment,
operationalization, monitoring and closure of treatment and rehabilitation
facilities.
l. Receive, gather, collect and evaluate all information on the
importation, exportation, production, manufacture, sale, stocks, seizures
of and the estimated need for any dangerous drug and/or controlled
precursor and essential chemical, for which purpose the Board may
require from any official, instrumentality or agency of the government or
any private person or enterprise dealing in, or engaged in activities
having to do with any dangerous drug and/or controlled precursor and
essential chemical such data or information as it may need to implement
the Act;
m. Gather and prepare detailed statistics on the importation
exportation, manufacture, stocks, seizures of and estimated need for anydangerous drug and/or controlled precursor and essential chemical and
such other statistical data on said drugs as may be periodically required
by the United Nations Commission on Narcotic Drugs, the World Health
Organization and other international organizations in consonance with
the country's international commitments;
n. Develop and maintain international networking coordination with
international drug control agencies and organizations, and implement the
provisions of international conventions and agreements thereon which
have been adopted and approved by the Congress of the Philippines;
o. Require all government and private hospitals, clinics, doctors,
dentists and other practitioners to submit a report to the Board, in
coordination with the PDEA, about all dangerous drugs and/or controlled
precursors and essential chemicals-related cases to which they have
attended for statistics and research purposes;
p. Receive in trust legacies, gifts and donations of real and personal
properties of all kinds, to administer and dispose of the same when
necessary for the benefit of government and private rehabilitation centers
subject to limitations, directions and instructions from the donors, if any;
q. Issue guidelines as to the approval or disapproval of applications
for voluntary treatment, rehabilitation or confinement, wherein it shall
issue the necessary guidelines, rules and regulations pertaining to the
application and its enforcement;
r. Formulate guidelines, in coordination with other government
agencies, the importation, distribution, production, manufacture,
compounding, prescription, dispensing and sale of, and other lawful acts
in connection with any dangerous drug, controlled precursor and
essential chemical and other similar or analogous substances of such kind
and in such quantity as it may deem necessary according to the medical
and research needs or requirements of the country including diet pills
containing ephedrine and other addictive chemicals and determine the
quantity and/or quality of dangerous drugs and precursors and essential
chemicals to be imported, manufactured and held in stock at any given
time by authorized importer, manufacturer or distributor of such drugs:
Provided, that the corresponding license for this purpose shall be issued
by the PDEA;
s. Develop, in consultation with concerned agencies, the utilization
of a controlled delivery scheme in addressing the transshipment of
dangerous drugs into and out of the country to neutralize transnational
crime syndicates involved in illegal trafficking of any dangerous drug
and/or controlled precursor and essential chemical for implementation by
the PDEA in collaboration with other agencies and foreign counterparts;
t. Recommend the revocation of the professional license of any
practitioner who is an owner, co-owner, lessee, or in the employ of the
drug establishment, or manager of a partnership, corporation, association,
or any juridical entity owning and/or controlling such drugestablishment, and who knowingly participates in or consents to
tolerates, or abets the commission of the act of violations as indicated in
the preceding paragraph, all without prejudice to the criminal prosecution
of the person responsible for the said violation;
u. Appoint such technical, administrative and other personnel as
may be necessary for the effective implementation of the Act, subject to
the Civil Service Law and its rules and regulations;
v. Establish a regular and continuing consultation with concerned
government agencies and medical professional organizations to
determine if balance exists in policies, procedures, rules and regulations
on dangerous drugs and to provide recommendations on how the lawful
use of dangerous drugs can be improved and facilitated;
w. Approve changes in the organizational set-up of PDEA as
submitted by the Director General of the PDEA, as provided for under
Section 83;
x. Approve the establishment of the PDEA Academy either in
Baguio or Tagaytay City, and in such other places as may be necessary,
and provide for the qualifications and requirements of PDEA recruits
who must be at least twenty-one (21) years old, of proven integrity and
honesty and a baccalaureate degree holder, as provided for under Section
85;
y. Reclassify, add to or remove any dangerous drug from, the lists of
dangerous drugs and controlled precursors and essential chemicals, as
provided for under Section 93;
z. Receive from DOH all income derived from fees for drug
dependency examinations and other medical and legal services provided
to the public which shall be constituted as a special funds for the
implementation of the Act, as provided for under Section 76(f);
aa) Receive fines, fees, net proceeds of any sale or
disposition of any property confiscated of forfeited, and other
income authorized and imposed under the Act, including ten
per cent (10%) of all unclaimed and forfeited sweepstakes
and lotto prizes but not less than Twelve million pesos
(P12,000,000.00) per year from the Philippine Charity
Sweepstakes Office (PCSO), and Five million pesos
(P5,000,000.00) a month from PAGCOR, which shall
constitute as special account in the general fund for the
implementation of the Act, excluding the operating expenses
of the Board and other concerned agencies at least fifty per
cent (50%) of all funds which shall be reserved for assistance
to government-owned and/or operated rehabilitation centers,
as provided for under Sections 76(f) and 87.
bb) Recommend to the concerned agency the grant of
compensation, reward and award to any person providinginformation and to law enforcers participating in a successful
drug operation, as provided for in Section 22;
cc) Manage the funds as it may deem proper for the
attainment of the objectives of the Act. The Chairperson of
the Board shall submit to the President of the Philippines and
the Presiding Officers of both Houses of Congress, within
fifteen (15) days from the opening of the regular session, an
annual report on the dangerous drugs situation in the country
which shall include detailed account of the programs and
projects undertaken, statistics on crimes related to dangerous
drugs, expenses incurred pursuant to the provisions of the
Act; recommended remedial legislation, If needed, and such
other relevant facts as it may deem proper to cite, as provided
for under Section 88; and
dd) Submit an annual and periodic reports to the President,
the Congress of the Philippines and the Senate and House of
Representatives Committees concerned as may be required
from time to time, and perform such other functions as may
be authorized or required under existing laws and as directed
by the President himself/herself or as recommended by the
Congressional Committees concerned.
SECTION 82. Creation of the Philippine Drug Enforcement Agency (PDEA). —
To carry out the provisions of the Act, the PDEA, which serves as the implementing
arm of the Board, shall be responsible for the efficient and effective law enforcement
of all the provisions on any dangerous drug and/or controlled precursor and essential
chemical as provided in the Act.
The PDEA shall be headed by a Director General with the rank of Undersecretary,
who shall be responsible for the general administration and management of the
Agency. The Director General of the PDEA shall be appointed by the President of
the Philippines and shall perform such other duties that may be assigned to him/her.
He/she must possess adequate knowledge, training and experience in the field of
dangerous drugs, and in any of the following fields: law enforcement, law, medicine,
criminology, psychology or social work.
The Director General of the PDEA shall be assisted in the performance of his/her
duties and responsibilities by two (2) deputy director generals with the rank of
Assistant Secretary, one for Operations and the other one for Administration. The
two (2) deputy director generals shall likewise be appointed by the President of the
Philippines upon recommendation of the Board. The two (2) deputy director
generals shall possess the same qualifications as those of the Director General of the
PDEA. The Director General and the two (2) deputy director generals shall receive
the compensation and salaries as prescribed by law.
SECTION 83. Organization of the PDEA. — The present Secretariat of the
National Drug Law Enforcement and Prevention Coordinating Center (DEP Center)
as created by Executive Order No. 61 shall be accordingly modified and absorbed by
the PDEA.The Director General of the PDEA shall be responsible for the necessary changes in
the organizational set-up which shall be submitted to the Board for approval.
For purposes of carrying out its duties and powers as provided for in the succeeding
Section of this IRR, the PDEA shall have the following Services, namely:
Intelligence and Investigation; International Cooperation and Foreign Affairs;
Preventive Education and Community Involvement; Plans and Operations;
Compliance; Legal and Prosecution; Administrative and Human Resource; Financial
Management; Logistics Management; and Internal Affairs.
The PDEA shall establish and maintain regional offices in the different regions of
the country which shall be responsible for the implementation of the Act and the
policies, programs, and projects of said agency in their respective regions.
SECTION 84. Powers and Duties of the PDEA. — The PDEA shall:
a. Implement or cause the efficient and effective implementation of
the national drug control strategy formulated by the Board thereby
carrying out a national anti-drug campaign program which shall include
drug law enforcement, control and prevention campaign with the
assistance of concerned government agencies.
b. Undertake the enforcement of the provisions of Article II of the
Act relative to the unlawful acts and penalties involving any dangerous
drug and/or controlled pre-cursor and essential chemical and investigate
all violators and other matters involved in the commission of any crime
relative to the use, abuse or trafficking of any dangerous drug and/or
controlled precursor and essential chemical as provided for in the Act and
the provisions of Presidential Decree No. 1619;
c. Administer oath, issue subpoena and subpoena duces tecum
relative to the conduct of investigation involving the violations of the
Act;
d. Arrest and apprehend as well as search all violators and seize or
confiscate, the effects or proceeds of the crimes as provided by law and
take custody thereof, for this purpose the prosecutors and enforcement
agents are authorized to possess firearms, in accordance with existing
laws;
e. Take charge and have custody of all dangerous drugs and/or
controlled pre-cursors and essential chemicals seized, confiscated or
surrendered to any national, provincial or local law enforcement agency,
if no longer needed for purposes of evidence in court;
f. Establish forensic laboratories in each PNP office in every
province and city in order to facilitate action on seized or confiscated
drugs, thereby hastening the destruction of the same without delay;
g. Recommend to the DOJ the forfeiture of properties and other
assets of persons and/or corporations found to be violating the provisionsof the Act and in accordance with the pertinent provisions of the Anti-
Money Laundering Act of 2001;
h. Prepare for prosecution or cause the filing of appropriate criminal
and civil cases for violation of all laws on dangerous drugs, controlled
precursors and essential chemicals, and other similar controlled
substances, and assist; support and coordinate with other government
agencies for the proper and effective prosecution of the same;
i. Monitor and if warranted by circumstances, in coordination with
the Philippine Postal Office and the Bureau of Customs, inspect all air
cargo packages, parcels and mails in the central post office, which appear
from the package and address itself to be a possible importation of
dangerous drugs and/or controlled precursors and essential chemicals,
through, on-line or cyber shops via the internet or cyberspace;
j. Conduct, eradication programs to destroy wild or illegal growth
of plants from which dangerous drugs may be extracted;
k. Initiate and undertake the formation of a nationwide organization
which shall coordinate and supervise all activities against drug abuse in
every province, city, municipality and barangay with the active and direct
participation of all such local government units and non-government
organizations, including the citizenry, subject to the provisions of
previously formulated programs of action against dangerous drugs;
l. Establish and maintain a national drug intelligence system in
cooperation with law enforcement agencies, other government
agencies/offices and local government units that will assist in its
apprehension of big-time lords;
m. Establish and maintain close coordination, cooperation and
linkages with international drug control and administration agencies and
organizations, and implement the applicable provisions of international
conventions and agreements related to dangerous drugs to which the
Philippines is a signatory;
n. Create and maintain an efficient special enforcement unit to
conduct investigation, file charges and transmit evidence to the proper
court, wherein members of the said unit shall possess suitable and
adequate firearms for their protection in connection with the performance
of their duties: Provided, that no previous special permit for such
possession shall be required;
o. Require all government and private hospitals, clinics, doctors,
dentists and other practitioners to submit a report to it, in coordination
with the Board, about all dangerous drugs and/or controlled precursors
and essential chemicals which they have attended to for data and
information purposes;
p. Coordinate with the Board for the facilitation of the issuance of
necessary guidelines, rules and regulations for the proper implementationof the Act;
q. Initiate and undertake a national campaign for drug abuse
prevention and drug control programs, where it may enlist the assistance
of any department, bureau, office, agency or instrumentality of the
government, including government-owned and/or controlled
corporations, in the anti-illegal drugs drive, which may include the use of
their respective personnel, facilities, and resources for a more resolute
detection and investigation of drug-related crimes and prosecution of the
drug traffickers; and
r. Submit an annual and periodic reports to the Board as may be
required from time to time, and perform such other functions as may be
authorized or required under existing laws and as directed by the
President himself/herself or as recommended by the Congressional
Committees concerned.
SECTION 85. The PDEA Academy. — Upon the approval of the Board, the PDEA
Academy shall be established either in Baguio or Tagaytay City, and in such other
places as may be necessary. The PDEA Academy shall be responsible in the
recruitment and training of all PDEA agents and personnel. The Board shall provide
for the qualifications and requirements of its recruits who must be at least twenty-
one (21) years old, of proven integrity and honesty and a baccalaureate degree
holder.
The graduates of the Academy shall later comprise the operating units of the PDEA
after the termination of the transition period of five (5) years during which all the
intelligence network and standard operating procedures of the PDEA has been set up
and operationalized.
The Academy shall be headed by a Superintendent, with the rank of Director. He/she
shall be appointed by the PDEA Director General.
SECTION 86. Transfer, Absorption, and Integration of All Operating Units on
Illegal Drugs into the PDEA and Transitory Provisions. — The Narcotics Group of
the PNP, the Narcotics Division of the NBI and the Customs Narcotics Interdiction
Unit are hereby abolished, however, they shall continue with the performance of
their task as detail service with the PDEA, subject to screening, until such time that
the organizational structure of the Agency is fully operational and the number of
graduates of the PDEA Academy is sufficient to do the task themselves: Provided,
that such personnel who are affected shall have the option of either being integrated
into the PDEA or remain with their original mother agencies and shall thereafter, be
immediately re-assigned to other units therein by the head of such agencies. Such
personnel who are transferred, absorbed and integrated in the PDEA shall be
extended appointments to positions similar in rank, salary and other emoluments and
privileges granted to their respective positions in their original mother agencies.
The transfer, absorption and integration of the different offices and units provided
for in this Section shall take effect within eighteen (18) months from the effectivity
of the Act: Provided, that personnel absorbed and on detail service shall be given
until five (5) years to finally decide to join the PDEA.Nothing in the Act shall mean a diminution of the investigative powers of the NBI
and the PNP on all other crimes as provided for in their respective organic laws:
Provided, however, that when the investigation being conducted by the NBI, the
PNP or any ad hoc anti-drug task force is found to be a violation of any of the
provisions of the Act, the PDEA shall be the lead agency. The NBI, the PNP or and
any of the task force shall immediately transfer the same to the PDEA; Provided,
further, that the NBI, the PNP and the Bureau of Customs shall maintain close
coordination with the PDEA on all drug related matters.
a. Relationship/Coordination between the PDEA and Other
Agencies. — The PDEA shall be the lead agency in the enforcement of
the Act, while the PNP, the NBI and other law enforcement agencies
shall continue to conduct anti-drug operations in support of the PDEA:
Provided, that the said agencies shall, as far as practicable, coordinate
with the PDEA prior to anti-drug operations; Provided, further, that, in
any cases, said agencies shall inform the PDEA of their anti-drug
operations within twenty-four (24) hours from the time of the actual
custody of the suspects or seizure of said drugs and substances, as well as
paraphernalia and transport equipment used in illegal activities involving
such drugs and/or substances, and shall regularly update the PDEA on
the status of the cases involving the said anti-drug operations; Provided,
furthermore, that raids, seizures, and other anti-drug operations
conducted by the PNP; the NBI, and other law enforcement agencies
prior to the approval of this IRR shall be valid and authorized; Provided,
finally, that nothing in this IRR shall deprive the PNP, the NBI, other law
enforcement personnel and the personnel of the Armed Forces of the
Philippines (AFP) from effecting lawful arrests and seizures in
consonance with the provisions of Section 5, Rule 113 of the Rules of
Court.
b. Roles of the PNP, NBI, Bureau of Customs and Other Law
Enforcement Agencies — The PDEA may enter into a Memorandum of
Agreement (MOA) with the PNP, the NBI, the Bureau of Customs and
other law enforcement agencies to carry out the implementation of the
Act, provided that the respective MOAs shall include specific roles of
enumerated agencies in the administrative and operational matters. Said
MOAs shall be entered into by the PDEA and the respective agencies
fifteen (15) days after the implementation of this IRR.
ARTICLE X
Appropriations, Management of Funds and Annual Report
SECTION 87. Appropriations. — The amount necessary for the operation of the
Board and the PDEA shall be charged against the current year's appropriations of the
Board, the DEP Center, the Narcotics Group of the PNP, the Narcotics Division of
the NBI and other drug abuse units of the different law enforcement agencies
integrated into the PDEA in order to carry out the provisions of the Act. Thereafter,
such sums as may be necessary for the continued implementation of the Act shall be
included in the annual General Appropriations Act.
All receipts derived from fines, fees and other income authorized and imposed in the
Act, including ten percent (10%) of all unclaimed and forfeited sweepstakes andlotto prizes but not less than Twelve million pesos (P12,000,000.00) per year from
the Philippine Charity Sweepstakes Office (PCSO), are hereby constituted as a
special account in the general fund for the implementation of the Act: Provided, that
no amount shall be disbursed to cover the operating expenses of the Board and other
concerned agencies; Provided, further, that at least fifty percent (50%) of all the
funds shall be reserved for assistance to government-owned and/or operated
rehabilitation centers.
The fines shall be remitted to the Board by the court imposing such fines within
thirty (30) days from the finality of its decisions or orders. The unclaimed and
forfeited prizes shall be turned over to the Board by the PCSO within thirty (30)
days after these are collected and declared forfeited.
A portion of the funds generated by the Philippine Amusement and Gaming
Corporation (PAGCOR) in the amount of Five million pesos (P5,000,000.00) a
month shall be set aside for the purpose of establishing adequate drug rehabilitation
centers in the country and also for the maintenance and operations of such centers:
Provided, that the said amount shall be taken from the fifty percent (50%) share of
the National Government in the income of PAGCOR; Provided, further, that the said
amount shall automatically be remitted by PAGCOR to the Board. The amount
shall, in turn, be disbursed by the Board, subject to the rules and regulations of the
Commission on Audit (COA).
The fund may be augmented by grants, donations, and endowment from various
sources, domestic or foreign, for purposes related to their functions, subject to the
existing guidelines set by the government.
a. No money shall be paid out of the National Treasury for the current operating
and capital outlay requirement of the programs, projects and activities of the Board
and the PDEA, including those funded from the Special Account in the General
Fund (SAGF) constituted under Section 87 of the Act and the next succeeding Rule,
except in pursuance of an express appropriation made by Congress in the annual
General Appropriations Act. Until such time that such an express appropriation is
made, the amounts necessary for the operation of the new DDB and PDEA shall be
in-charged against the current year's appropriation of the old DDB of the DOH, the
DEP Center, the Narcotics Group of the PNP, the Narcotics Division of the NBI and
other drug enforcement units of the different law enforcement agencies integrated
into the PDEA, subject to such guidelines as may be issued by DBM for the purpose.
b. The Bureau of Treasury (BTr) shall open a SAGF in favor of the Board to
which shall be deposited the following:
b.1 Receipts derived from fines which shall be remitted by the court
imposing such fines within thirty (30) days from the finality of its
decisions or orders;
b.2 Ten percent (10%) of all unclaimed and forfeited sweepstakes and
lotto prizes, but in no case less than Twelve million pesos
(P12,000,000.00) per year, which shall be remitted by the PCSO within
thirty (30) days after these are collected and declared forfeited;b.3 Proceeds from fees and other incomes authorized and imposed
pursuant to the Act;
b.4 The Five million pesos (P5,000,000.00) monthly share of the Board
from the fifty percent (50%) statutory share of the National Government
in the income of the PAGCOR which shall automatically remit the same;
and
b.5 Grants, donations and endowments from various sources, domestic
or foreign, for purposes relative to their functions and subject to existing
guidelines.
c. Release against the SAGF shall be governed by Section 35, Chapter 5, Book
VI of E.O. No. 292 (The Administrative Code of 1987), the established
programming considerations, and the observance of the following conditions
specified by the Act:
c.1 At least fifty percent (50%) of the total receipts derived from fines,
fees and other income authorized and imposed under the Act, including
the ten percent (10%) of all unclaimed and forfeited sweepstakes and
lotto prizes from PCSO, shall be reserved for assistance to drug treatment
and rehabilitation centers owned and/or operated by the National
Government and its political subdivisions and that no amount in the total
of such receipts shall be disbursed to cover the operating expenses of the
Board, the PDEA, and other concerned agencies; and
c.2 The Five million pesos (P5,000,000.00) monthly share of the Board
from the fifty percent (50%) statutory share of the National Government
from the PAGCOR income shall be used exclusively for the
establishment and maintenance of new drug treatment and rehabilitation
centers in the country, as well as the operation and maintenance of
existing ones.
SECTION 88. Management of Funds Under the Act: Annual Report by the Board
and the PDEA. —
a. Fund Management. — The Board and the PDEA shall manage
their respective funds, whether appropriated by Congress or coming from
other sources, as each may deem proper for the attainment of the
objectives of the Act, and respectively account for the same, subject to
the observance of the terms and conditions set in the annual general
appropriations act and pertinent budgeting, accounting and auditing rules
and regulations.
b. Annual Report. — In addition to the periodic reports prescribed
elsewhere in this IRR, the Chairperson of the Board shall submit to the
President of the Philippines and to the presiding officers of the two
chambers of Congress, within fifteen (15) days from the opening of the
regular session, an annual report on the dangerous drugs situation in the
country which shall include detailed account of the programs and
projects undertaken, statistics on crimes related to the dangerous drugs,
expenses incurred in pursuit of the mandate set under the Act,recommended remedial legislation, if needed, and such other relevant
facts as it may deem proper to cite.
SECTION 89. Auditing the Accounts and Expenses of the Board and the PDEA. —
All accounts and expenses of the Board and the PDEA shall be audited by the COA
or its duly authorized representative.
ARTICLE XI
Jurisdiction Over Dangerous Drugs Cases
SECTION 90. Jurisdiction. — The Supreme Court shall designate special courts
from among the existing Regional Trial Courts in each judicial region to exclusively
try and hear cases involving violations of the Act. The number of courts designated
in each judicial region shall be based on the population and the number of cases
pending in their respective jurisdiction.
The DOJ, through its provincial/city prosecution offices, shall designate special
prosecutors to exclusively handle cases involving violations of the Act.
The preliminary investigation of cases filed under the Act shall be terminated within
a period of thirty (30) days from the date of their filing.
When the preliminary investigation is conducted by a public prosecutor and a
probable cause is established, the corresponding information shall be filed in court
within twenty-four (24) hours from the termination of the investigation. If the
preliminary investigation is conducted by a judge and a probable cause is found to
exist, the corresponding information shall be filed by the proper prosecutor within
forty-eight (48) hours from the date of receipt of the records of the case.
However, when the prosecutor disagrees with the finding of the Municipal Trial
Court and he/she finds the need to conduct a formal reinvestigation of the case to
clarify issues, or to afford either party the opportunity to be heard to avoid
miscarriage of justice, the prosecutor has to terminate the reinvestigation within
fifteen (15) days from receipt of the records, and if probable cause exists, to file the
corresponding information in court within forty-eight (48) hours from termination of
the reinvestigation.
Trial of the case under this Section shall be finished by the court not later than sixty
(60) days from the date of the filing of the information. Decision on said cases shall
be tendered within a period of fifteen (15) days from the date of submission of the
case for resolution.
SECTION 91. Responsibility and Liability of Law Enforcement Agencies and other
Government Officials and Employees in Testifying as Prosecution Witnesses in
Dangerous Drugs Cases. — Any member of law enforcement agencies or any other
government official and employee who, after due notice, fails or refuses
intentionally or negligently, to appear as a witness for the prosecution in any
proceeding, involving violations of the Act, without any valid reason, shall be
punished with imprisonment of not less than twelve (12) years and one (1) day to
twenty (20) years and a fine of not less than Five hundred thousand pesos
(P500,000.00), in addition to the administrative liability he/she may be meted out by
his/her immediate superior and/or appropriate body.The immediate superior of the member of the law enforcement agency or any other
government employee mentioned in the preceding paragraph shall be penalized with
imprisonment of not less than two (2) months and one (1) day but not more than six
(6) years and a fine of not less than Ten thousand pesos (P10,000.00) but not more
than Fifty thousand pesos (P50,000.00) and in addition, perpetual absolute
disqualification from public office if despite the due notice to them and to the
witness concerned, the former does not exert reasonable effort to present the latter to
the court.
The member of the law enforcement agency or any other government employee
mentioned in the preceding paragraphs shall not be transferred or re-assign to any
other government office located in another territorial jurisdiction during the
pendency of the case in court. However, the concerned member of the law
enforcement agency or government employee may be transferred or re-assign for
compelling reasons. Provided, that his/her immediate superior shall notify the court
in writing where the case is pending of the order to transfer or re-assign, within
twenty-four (24) hours from its approval, Provided, further, that his/her immediate
superior shall penalized with imprisonment of not less than two (2) months and one
(1) day but not more than six (6) years and a fine of not less than Ten Thousand
pesos (10,000.00) but not more than fifty thousand pesos (P50,000.00) and in
addition, perpetual absolute disqualification from public office, should he/she fail to
notify the court in writing of such order to transfer of re-assign.
Prosecution and punishment under this Section shall be without prejudice to an
liability for violation of any existing law.
SECTION 92. Delay and Bungling in the Prosecution of Drug Cases. — Any
government officer or employee tasked with the prosecution of drug-related cases
under the Act, either as prosecutor, prosecution witness, or as law enforcement
agent, who, through patent laxity, inexcusable neglect, unreasonable delay or
deliberately causes the unsuccessful prosecution and/or dismissal of the said drug
cases, shall suffer the penalty of imprisonment ranging from twelve (12) years and
one (1) day to twenty (20) years without prejudice to his/her prosecution under the
pertinent provisions of the Revised Penal Code.
SECTION 93. Reclassification, Addition or Removal of Any Drug from the List of
Dangerous Drugs. — The Board shall have the power to reclassify; add to or
remove from the list of dangerous drugs. Proceedings to reclassify, add or remove a
drug or other substance may be initiated by the PDEA, the DOH, or by petition from
any interested party, including the manufacturer of a drug, a medical society or
association, a pharmacy association, a public interest group concerned with drug
abuse, a national or local government agency, or an individual citizen. When a
petition is received by the Board, it shall immediately begin its own investigation of
the drug. The PDEA also may begin an investigation of a drug at any time based
upon the information received from law enforcement laboratories, national and local
law enforcement and regulatory agencies, or other sources of information.
The Board after notice and hearing shall consider the following factors with respect
to each substance proposed to be reclassified, added or removed from control:
a. Its actual or relative potential for abuse;b. Scientific evidence of its pharmacological effect if known;
c. The state of current scientific knowledge regarding the drug or
other substance;
d. Its history and current pattern of abuse;
e. The scope, duration, and significance of abuse;
f. Risk to public health; and
g. Whether the substance is an immediate precursor of a substance
already controlled under the Act.
The Board shall also take into accord the obligations and commitments to
international treaties, conventions and agreements to which the Philippines is a
signatory.
The Dangerous Drugs Board shall give notice to the general public of the public
hearing of the reclassification, addition to or removal from the list of any drug by
publishing such notice in any newspaper of general circulation once a week for two
(2) weeks.
The effect of such reclassification, addition or removal shall be as follows:
a. In case a dangerous drug is reclassified as precursor and essential
chemical, the penalties for the violations of the Act pertaining to
precursors and essential chemicals shall, in case of conviction, be
imposed in all pending criminal prosecutions;
b. In case a precursor and essential chemical is reclassified as
dangerous drug, the penalties for violations of the Act involving
precursors and essential chemicals shall, in case of conviction, be
imposed in all pending criminal prosecutions;
c. In case of the addition of a new drug to the list of dangerous drugs
and precursors and essential chemicals, no criminal liability involving
the same under the Act shall arise until after the lapse of fifteen (15) days
from the last publication of such notice;
d. In case of removal of a drug from the list of dangerous drugs and
precursors and essential chemicals, all persons convicted and/or detained
for the use and/or possession of such a drug shall be automatically
released and all pending criminal prosecution involving such a drug
under the Act shall forthwith be dismissed; and
e. The Board shall, within five (5) days from the date of its
promulgation, submit to Congress a detailed reclassification, addition, or
removal of any drug from the list of dangerous drugs.
ARTICLE XII
Final ProvisionsSECTION 94. Congressional Oversight Committee on Dangerous Drugs
(COCDD). — The COCDD created under Section 95 of the Act shall be composed
of seven (7) Members from the Senate and seven (7) Members from the House of
Representatives. The Members from the Senate shall be appointed by the Senate
President based on the proportional representation of the parties or coalitions therein
with at least two (2) Senators representing the Minority. The Members from the
House of Representatives shall be appointed by the Speaker, also based on the
proportional representation of the parties or coalitions therein with at least two (2)
Members representing the Minority.
The COCDD shall beheaded by the respective Chairpersons of the Senate
Committee on Public Order and Illegal Drugs and the House of Representatives
Committee on Dangerous Drugs.
SECTION 95. Powers and Functions of the COCDD. — The COCDD shall, in aid
of legislation, perform the following functions, among others:
a. To set the guidelines and overall framework to monitor and ensure the
proper implementation of the Act;
b. To ensure transparency and require the submission of reports from
government agencies concerned on the conduct of programs, projects and
policies relating to the implementation of the Act;
c. To approve the budget for the programs of the COCDD and all
disbursements therefrom, including compensation of all personnel;
d) To submit periodic reports to the President of the Philippines and
Congress on the implementation of the provisions of the Act;
e. To determine inherent weaknesses in the law and recommend the
necessary, remedial legislation or executive measures; and
f. To perform such other duties, functions and responsibilities as may be
necessary to effectively attain the objectives of the Act.
SECTION 96. Adoption of Committee Rules and Regulations, and Funding. — The
COCDD shall adopt its internal rules of procedure, conduct hearings and receive
testimonies, reports, and technical advice, invite or summon by subpoena ad
testificandum any public official, private citizen, or any other person to testify before
it or require any person by subpoena duces tecum documents or other materials as it
may require consistent with the provisions of the Act.
The COCDD shall be assisted by a secretariat to be composed by personnel who
may be seconded from the Senate and the House of Representatives and may retain
consultants.
To carry out the powers and functions of the COCDD, the initial sum of Twenty-five
million pesos (P25,000,000.00) shall be charged against the current appropriations
of the Senate. Thereafter, such amount necessary for its continued operations shall
be included in the annual General Appropriations Act.The COCDD shall exist for a period of ten (10) years from the effectivity of the Act
and may be extended by a joint concurrent resolution.
SECTION 97. Limited Applicability of the Revised Penal Code. —
Notwithstanding any law, rule or regulation to the contrary, the provisions of the
Revised Penal Code (Act No. 3814), as amended, shall not apply to the provisions of
this IRR, except in the case of minor offenders. Where the offender is a minor, the
penalty for acts punishable by life imprisonment to death provided herein shall be
reclusion perpetua to death.
SECTION 98. Separability Clause. — If for any reason any section or provision of
this IRR, or any portion thereof, or the application of such Section, provision or
portion thereof to any person, group or circumstance is declared invalid or
unconstitutional, the remainder of this IRR shall not be affected by such declaration
and shall remain in force and effect.
SECTION 99. Repealing Clause. — All memorandum circulars, resolutions,
orders, and other issuances or parts thereof which are inconsistent with the Act or
with this IRR are hereby repealed, amended or modified accordingly.
SECTION 100. Implementing Details. — The Board shall issue such additional
implementing rules and regulations as may be necessary to further clarify any part of
this IRR
SECTION 101. Effectivity Clause. — This IRR shall take effect upon its publication
in three (3) newspapers of general circulation and upon registration with the Office
of the National Administrative Register at the University of the Philippines Law
Center, UP Diliman, Quezon City.
Adopted: 30 Aug. 2002.
(SGD.) CORAZON JULIANO- (SGD.) ANGELO T. REYES
SOLIMAN (Secretary of National Defense)
(Secretary of Social Welfare and Ex-Officio Member
Development)
Ex-Officio Member
(SGD.) RAMON C. BACANI (SGD.) BERNARDO T. LASTIMOSO
(Officer-In-Charge, Department of (Executive Director, Dangerous Drugs
Education) Board) Board Member
Ex-Officio Member
(SGD.) MANUEL M. DAYRIT (SGD.) HERNANDO B. PEREZ
(Secretary of Health) (Secretary of Justice)
Active Vice-Chair Acting ChairSource: Supreme Court E-Library
This page was dynamically generated
by the E-Library Content Management System (E-LibCMS)